1 |
-aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 2件: 96, 97 💬 |
2 |
0,25 mg rpc1063 |
- |
- |
- |
- |
096 1件: 96 💬 |
3 |
0.25 mg rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
4 |
0114-0006b |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
5 |
10 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
6 |
10% metronidazole ointment |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
096 1件: 96 💬 |
7 |
1000 iu d3 |
- |
- |
- |
- |
096 1件: 96 💬 |
8 |
13-valent pneumococcal conjugated vaccine (pcv13) |
- |
- |
- |
- |
096 1件: 96 💬 |
9 |
18f-fdg |
Fludeoxyglucose (18F) |
- |
- |
- |
005 12件: 5 , 6 , 7 , 13, 41, 46, 53, 84, 85, 96, 127, 300 💬 |
10 |
1mg rpc1063 |
- |
- |
- |
- |
096 1件: 96 💬 |
11 |
2'-fucosyllactose |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
12 |
23-valent polysaccharide pneumococcal vaccine |
- |
- |
- |
- |
096 1件: 96 💬 |
13 |
23-valent polysaccharide pneumococcal vaccine (pneumovax tm) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
14 |
25 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
15 |
3-hydroxy-2-methyl-4h-pyrane-4-one iron (iii) complex (3:1), ferric (3-hydroxy-2-methyl-4-pyrone), tris-maltol-iron (iii), tri=maltol-iron (iii) |
Tromethamine |
1件: D00396 D00396 💬 |
- |
- |
096 2件: 96, 97 💬 |
16 |
331731-18-1 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
17 |
4-aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 1件: 96 💬 |
18 |
4-aminosalicylic acid extended release granules |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 1件: 96 💬 |
19 |
40 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
20 |
40 mg msb11022 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
21 |
42942019 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
22 |
5-aminolevulinic acid |
Aminolevulinic acid |
2件: D02908 D02908, D07567 D07567 💬 |
- |
- |
096 1件: 96 💬 |
23 |
5-aminosalicyl acid |
- |
- |
- |
- |
096 1件: 96 💬 |
24 |
5-aminosalicylate (pentasa, ferring) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
25 |
5-aminosalicylic acid |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
26 |
5-asa |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 2件: 96, 97 💬 |
27 |
5-htp |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
28 |
5000 iu d3 |
- |
- |
- |
- |
096 1件: 96 💬 |
29 |
549-0261/f02-01 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
30 |
6 mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
31 |
6-[(methyl-4-nitro-1h-imidazol-5-yl)thio]-1h-purine |
- |
- |
- |
- |
096 1件: 96 💬 |
32 |
6-mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 3件: 96, 97, 164 💬 |
33 |
6-mercaptopurine (puri-nethol) |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 1件: 96 💬 |
34 |
6-mp |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
35 |
683699 |
- |
- |
- |
- |
096 1件: 96 💬 |
36 |
75 mg ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
37 |
80 mg dr-6mp |
- |
- |
- |
- |
096 1件: 96 💬 |
38 |
99mtc-s-hynic certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
39 |
?-3 polyunsaturated fatty acid |
- |
- |
- |
- |
096 1件: 96 💬 |
40 |
[124i]ib pf 06687234 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
41 |
[14c]-rpc1063 solution (0.1 mg/ml) for oral administration |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
42 |
[18f]fspg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
43 |
[cx601] |
- |
- |
- |
- |
096 1件: 96 💬 |
44 |
[ops-2071] |
- |
- |
- |
- |
096 1件: 96 💬 |
45 |
[rpc0163] |
- |
- |
- |
- |
096 1件: 96 💬 |
46 |
[rpc1063] |
- |
- |
- |
- |
096 1件: 96 💬 |
47 |
A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine |
Clarithromycin |
3件: D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 1件: 96 💬 |
48 |
A-1293543.74 |
- |
- |
- |
- |
096 1件: 96 💬 |
49 |
Ab1010 |
- |
- |
- |
- |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
50 |
Abatacept |
Abatacept |
1件: D03203 D03203 💬 |
CD80 2件: CD80, CD86 💬 |
Allograft rejection 12件: Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis |
011 26件: 11, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬 |
51 |
Abbv-066 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
52 |
Abr-215062 sodium salt |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
53 |
Abrilumab |
Abrilumab |
1件: D10540 D10540 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
54 |
Abt 494 12mg |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
55 |
Abt 494 3mg |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
56 |
Abt humira |
- |
- |
- |
- |
096 1件: 96 💬 |
57 |
Abt-494 |
- |
- |
- |
- |
041 6件: 41, 46, 49, 96, 97, 271 💬 |
58 |
Abt-874 |
- |
- |
- |
- |
096 1件: 96 💬 |
59 |
Abx464 |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
60 |
Accelerated 1 hour-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
61 |
Accelerated 30 minutes-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
62 |
Acetaminophen |
Acetaminophen |
1件: D00217 D00217 💬 |
PTGS1 2件: PTGS1, PTGS2 💬 |
Alzheimer disease 23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway |
011 14件: 11, 13, 34, 35, 46, 49, 51, 70, 86, 96, 222, 231, 256, 271 💬 |
63 |
Acetate |
Acetate |
- |
- |
- |
001 43件: 1 , 2 , 6 , 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 💬 |
64 |
Adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
019 16件: 19, 37, 40, 41, 46, 56, 84, 96, 97, 151, 160, 164, 222, 226, 269, 271 💬 |
65 |
Adalimumab (40 mg) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
66 |
Adalimumab (d2e7) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 271 💬 |
67 |
Adalimumab 40 mg eow or ew |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
68 |
Adalimumab and infliximab |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
69 |
Adalimumab injection |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
70 |
Adalimumab prn |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
71 |
Adsvf |
- |
- |
- |
- |
096 1件: 96 💬 |
72 |
Adult human mesenchymal stem cells |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
085 2件: 85, 96 💬 |
73 |
Agri-king synbiotic (aksb) |
- |
- |
- |
- |
096 1件: 96 💬 |
74 |
Ain457 |
- |
- |
- |
- |
013 7件: 13, 37, 41, 46, 56, 96, 271 💬 |
75 |
Albendazole |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
76 |
Albendazole (eskazole) |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
77 |
Albumen |
Egg white |
- |
- |
- |
096 1件: 96 💬 |
78 |
Albumine humaine |
- |
- |
- |
- |
096 1件: 96 💬 |
79 |
Aldesleukin |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
049 4件: 49, 65, 96, 97 💬 |
80 |
Alemtuzumab |
Alemtuzumab |
1件: D02802 D02802 💬 |
- |
- |
013 16件: 13, 15, 19, 20, 43, 44, 46, 51, 60, 63, 65, 85, 96, 164, 283, 284 💬 |
81 |
Alequel |
- |
- |
- |
- |
096 1件: 96 💬 |
82 |
Alfacalcidol |
Alfacalcidol |
1件: D01518 D01518 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
041 6件: 41, 46, 49, 50, 96, 235 💬 |
83 |
Alicaforsen |
Alicaforsen |
- |
- |
- |
096 2件: 96, 97 💬 |
84 |
Alicalm (polymeric liquid formula) |
- |
- |
- |
- |
096 1件: 96 💬 |
85 |
Allo-asc |
- |
- |
- |
- |
096 1件: 96 💬 |
86 |
Allo-asc-cd |
- |
- |
- |
- |
096 1件: 96 💬 |
87 |
Allogeneic bone marrow derived human mesenchymal stem cells (hmscs) |
- |
- |
- |
- |
096 1件: 96 💬 |
88 |
Allogeneic stem cell therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
89 |
Allogenic eascs 5 milion cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
90 |
Allogenic eascs 5 million cells/ml suspension for injection cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
91 |
Allogenic eascs 5 million cells/ml suspension for injection. cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
92 |
Allogenic eascs 5 million/ml suspension for injection. |
- |
- |
- |
- |
096 1件: 96 💬 |
93 |
Allopurinol |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
006 6件: 6 , 46, 57, 66, 96, 97 💬 |
94 |
Allopurinol sandoz 100 mg, tabletten |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
95 |
Allopurinol sodium |
Allopurinol |
1件: D00224 D00224 💬 |
XDH 1件: XDH 💬 |
Caffeine metabolism 5件: Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome, Purine metabolism |
096 1件: 96 💬 |
96 |
Alofisel |
- |
- |
- |
- |
096 1件: 96 💬 |
97 |
Alx-0600 |
- |
- |
- |
- |
096 1件: 96 💬 |
98 |
Amg 139 |
- |
- |
- |
- |
096 1件: 96 💬 |
99 |
Amg 181 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
100 |
Amg 827 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
101 |
Amg 827 210 mg |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
102 |
Amg 827 350 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
103 |
Amg 827 700 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
104 |
Amgevita |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
105 |
Amgevita (adalimumab biosimilar ) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
106 |
Amgevita 40 mg injektionslösung im fertigpen |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
107 |
Amgevita 40 mg injektionslösung in einer fertigspritze |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
108 |
Amgevita 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
109 |
Amgevita® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
110 |
Aminolevulinic acid |
Aminolevulinic acid |
2件: D02908 D02908, D07567 D07567 💬 |
- |
- |
034 3件: 34, 96, 286 💬 |
111 |
Aminosalicylic acid |
Aminosalicylic acid |
1件: D00162 D00162 💬 |
- |
- |
096 2件: 96, 97 💬 |
112 |
Ammonium chloride |
Ammonium chloride |
1件: D01139 D01139 💬 |
- |
- |
096 1件: 96 💬 |
113 |
Amoxicillin |
Amoxicillin |
3件: D00229 D00229, D02925 D02925, D07452 D07452 💬 |
- |
- |
006 7件: 6 , 46, 63, 96, 97, 222, 299 💬 |
114 |
An100226 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
115 |
Andecaliximab |
- |
- |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
116 |
Andosan |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
117 |
Anti tnf |
- |
- |
- |
- |
096 1件: 96 💬 |
118 |
Anti tnf alfa. |
- |
- |
- |
- |
096 1件: 96 💬 |
119 |
Anti tnf humanized antibody fab fragment-peg conjugate |
- |
- |
- |
- |
096 1件: 96 💬 |
120 |
Anti tnf therapy including infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
121 |
Anti-cd3 |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
122 |
Anti-cd3 monoclonal antibody |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
123 |
Anti-il-12 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
124 |
Anti-il-23 monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
125 |
Anti-il-6 mab |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
126 |
Anti-interferon-gamma monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
127 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
128 |
Anti-interleukin-23 immunoglobulin g2 (igg2) human monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
129 |
Anti-interleukin-6 monoclonal antibody |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
130 |
Anti-madcam antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
131 |
Anti-thymocyte globulin (rabbit) |
Rabbit |
- |
- |
- |
060 4件: 60, 65, 96, 285 💬 |
132 |
Anti-tnf |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
133 |
Anti-tnf discontinuation: physiological saline solution |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
134 |
Anti-tnf drug |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
135 |
Anti-tnf therapy |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
136 |
Anti-tnf: infliximab (infusion) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
137 |
Anti-tnf:adalimumab (subcutaneus) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
138 |
Anticorpo monoclonale anti il-23 |
- |
- |
- |
- |
096 1件: 96 💬 |
139 |
Anticorpo monoclonale anti-il-23 |
- |
- |
- |
- |
096 1件: 96 💬 |
140 |
Antithymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
141 |
Antithymocyte immunoglobulin (rabbit) |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
142 |
Apd334 |
- |
- |
- |
- |
093 4件: 93, 96, 97, 269 💬 |
143 |
Apd371 |
- |
- |
- |
- |
096 1件: 96 💬 |
144 |
Apixaban |
Apixaban |
1件: D03213 D03213 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 3件: 96, 97, 222 💬 |
145 |
Apixaban 2.5 milligram |
Apixaban |
1件: D03213 D03213 💬 |
F10 1件: F10 💬 |
Complement and coagulation cascades 1件: Complement and coagulation cascades |
096 2件: 96, 97 💬 |
146 |
Application of adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
147 |
Ar401959 l-arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
096 2件: 96, 97 💬 |
148 |
Arginine |
Arginine |
1件: D02982 D02982 💬 |
- |
- |
046 9件: 46, 67, 78, 96, 97, 113, 210, 251, 299 💬 |
149 |
As |
- |
- |
- |
- |
046 6件: 46, 53, 96, 97, 215, 271 💬 |
150 |
Asa |
- |
- |
- |
- |
013 4件: 13, 96, 97, 251 💬 |
151 |
Asc |
- |
- |
- |
- |
036 4件: 36, 51, 96, 97 💬 |
152 |
Ascs |
- |
- |
- |
- |
053 2件: 53, 96 💬 |
153 |
Ascs: adipose derived stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
154 |
Ast-120 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
155 |
Atg |
- |
- |
- |
- |
013 4件: 13, 60, 96, 285 💬 |
156 |
Atorvastatin |
Atorvastatin |
3件: D00258 D00258, D00887 D00887, D07474 D07474 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 17件: 13, 46, 49, 51, 58, 63, 79, 84, 88, 93, 96, 160, 222, 225, 265, 271, 299 💬 |
157 |
Autologous adipose derived stromal vascular fraction |
- |
- |
- |
- |
096 1件: 96 💬 |
158 |
Autologous cd34-selected peripheral blood stem cells transplant |
- |
- |
- |
- |
096 1件: 96 💬 |
159 |
Autologous mesenchymal stromal cell |
- |
- |
- |
- |
096 2件: 96, 298 💬 |
160 |
Autologous ovalbumin-specific type 1 regulatory t lymphocytes expanded population |
- |
- |
- |
- |
096 1件: 96 💬 |
161 |
Autologous stem cell transplantation |
- |
- |
- |
- |
056 2件: 56, 96 💬 |
162 |
Aza |
- |
- |
- |
- |
011 4件: 11, 40, 96, 97 💬 |
163 |
Azathioprin |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
164 |
Azathioprin-ratiopharm 25 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
165 |
Azathioprin-ratiopharm 25mg filmtabletten |
- |
- |
- |
- |
096 1件: 96 💬 |
166 |
Azathioprin-ratiopharm 50 mg filmtabletten |
- |
- |
- |
- |
096 1件: 96 💬 |
167 |
Azathioprine |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
006 20件: 6 , 11, 13, 19, 35, 42, 43, 44, 45, 46, 49, 63, 65, 66, 85, 94, 95, 96, 97, 162 💬 |
168 |
Azathioprine (aza) caps |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
169 |
Azathioprine (aza) or 6-mercaptopurine (6-mp) |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
170 |
Azathioprine - ratiopharm 50 mg |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
171 |
Azathioprine / 6 mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 1件: 96 💬 |
172 |
Azathioprine in case of endoscopic recurrence |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
173 |
Azathioprine individualised dose |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
174 |
Azathioprine or 6-mercaptopurine |
Azathioprine |
4件: D00161 D00161, D00238 D00238, D03033 D03033, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 2件: 96, 97 💬 |
175 |
Azathioprine or adalimumab and infliximab |
Adalimumab |
4件: D00238 D00238, D02597 D02597, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
176 |
Azathioprine or mesalazine |
Azathioprine |
3件: D00238 D00238, D00377 D00377, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
177 |
Azathioprine or methotrexate |
Azathioprine |
4件: D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 1件: 96 💬 |
178 |
Azathioprine weight-based dose |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
179 |
Azathioprine+enteral nutrition |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
096 1件: 96 💬 |
180 |
Azatioprina |
Azathioprine |
2件: D00238 D00238, D03033 D03033 💬 |
- |
- |
013 3件: 13, 96, 97 💬 |
181 |
Azd9056 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
182 |
Azithromycin |
Azithromycin |
3件: D02134 D02134, D06390 D06390, D07486 D07486 💬 |
- |
- |
013 6件: 13, 84, 85, 96, 228, 299 💬 |
183 |
Azithromycin + metronidazole |
Azithromycin |
6件: D00409 D00409, D02134 D02134, D05016 D05016, D05017 D05017, D06390 D06390, D07486 D07486 💬 |
- |
- |
096 1件: 96 💬 |
184 |
B. theta |
- |
- |
- |
- |
096 1件: 96 💬 |
185 |
Bacteriophage preparation |
- |
- |
- |
- |
096 1件: 96 💬 |
186 |
Bacteriotherapy |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
187 |
Bean |
Bean |
- |
- |
- |
096 1件: 96 💬 |
188 |
Behavioral: abbvie care 2.0 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
189 |
Behavioral: diet counseling |
- |
- |
- |
- |
096 1件: 96 💬 |
190 |
Behavioral: dyadic psychological support (dps) |
- |
- |
- |
- |
096 1件: 96 💬 |
191 |
Behavioral: hypnosis |
- |
- |
- |
- |
096 1件: 96 💬 |
192 |
Behavioral: tip / impact plus care coordination |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
193 |
Beta carotene |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
194 |
Beta carotene from dunaliella algae |
Beta carotene |
1件: D03101 D03101 💬 |
- |
- |
096 1件: 96 💬 |
195 |
Betamethasone |
Betamethasone |
7件: D00244 D00244, D00972 D00972, D01357 D01357, D01402 D01402, D01637 D01637, D02032 D02032, D02286 D02286 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 6件: 2 , 28, 46, 90, 96, 235 💬 |
196 |
Bezlotoxumab |
Bezlotoxumab |
1件: D10453 D10453 💬 |
- |
- |
096 2件: 96, 97 💬 |
197 |
Bfahf-2 |
- |
- |
- |
- |
096 1件: 96 💬 |
198 |
Bi 655066 |
- |
- |
- |
- |
096 2件: 96, 271 💬 |
199 |
Bi 655066 10 mg/ml |
- |
- |
- |
- |
096 1件: 96 💬 |
200 |
Bi 655066 90 mg/ml |
- |
- |
- |
- |
096 2件: 96, 271 💬 |
201 |
Bi 655130 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
202 |
Bi 695501 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
203 |
Bibr 796 bs, 20 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
204 |
Bibr 796 bs, 5 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
205 |
Bifidobacterium infantis |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97 💬 |
206 |
Bifidobacterium infantis 35624 |
Bifidobacterium longum infantis |
- |
- |
- |
096 2件: 96, 97 💬 |
207 |
Biological samplings |
- |
- |
- |
- |
096 1件: 96 💬 |
208 |
Biosimilar |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
209 |
Biosimilar infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
210 |
Bleomycin |
Bleomycin |
3件: D02177 D02177, D03229 D03229, D07535 D07535 💬 |
- |
- |
096 4件: 96, 278, 279, 280 💬 |
211 |
Bli-1300 high dose |
- |
- |
- |
- |
096 1件: 96 💬 |
212 |
Bli-1300 low dose |
- |
- |
- |
- |
096 1件: 96 💬 |
213 |
Blood and stools samples |
- |
- |
- |
- |
096 1件: 96 💬 |
214 |
Blood sampling |
- |
- |
- |
- |
013 5件: 13, 17, 19, 51, 96 💬 |
215 |
Bms-188667 |
- |
- |
- |
- |
046 8件: 46, 49, 53, 65, 96, 97, 222, 271 💬 |
216 |
Bms-936557 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
217 |
Bms-936557 (anti-ip-10 antibody) |
- |
- |
- |
- |
096 1件: 96 💬 |
218 |
Bms-945429 |
Clazakizumab |
1件: D10312 D10312 💬 |
- |
- |
046 2件: 46, 96 💬 |
219 |
Bms-986165 |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
220 |
Bms986165 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
221 |
Bone marrow derived mesenchymal stem cells (mscs) |
- |
- |
- |
- |
096 1件: 96 💬 |
222 |
Boulardii |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
223 |
Brazikumab |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
224 |
Brazikumab high dose |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
225 |
Brazikumab iv infusion |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
226 |
Brazikumab low dose |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
227 |
Brazikumab sc injection |
Brazikumab |
1件: D10912 D10912 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
228 |
Bt-11 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
229 |
Bt-11 1,000 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
230 |
Bt-11 1000mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
231 |
Bt-11 500 mg |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
232 |
Bt-11 active |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
233 |
Budenofalk |
- |
- |
- |
- |
096 1件: 96 💬 |
234 |
Budenofalk 3mg gastro-resistant capsules |
- |
- |
- |
- |
096 1件: 96 💬 |
235 |
Budenofalk 9mg gastro-resistant granules |
- |
- |
- |
- |
096 1件: 96 💬 |
236 |
Budesonide |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
066 9件: 66, 93, 94, 95, 96, 97, 98, 228, 299 💬 |
237 |
Budesonide ( zentacort capsules 3mg ) |
Budesonide |
1件: D00246 D00246 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
238 |
Bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
046 8件: 46, 51, 53, 70, 96, 168, 226, 298 💬 |
239 |
Bupivacaine/epinephrine/dexamethasone |
Bupivacaine |
14件: D00095 D00095, D00292 D00292, D00975 D00975, D00996 D00996, D01450 D01450, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02149 D02149, D02174 D02174, D02591 D02591, D02592 D02592, D07552 D07552 💬 |
ADRA1A 15件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, NR3C1, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
240 |
Bupropion |
Bupropion |
3件: D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
008 5件: 8 , 18, 21, 96, 171 💬 |
241 |
By demand |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
242 |
C326, il-6 inhibitory avimer protein |
- |
- |
- |
- |
096 1件: 96 💬 |
243 |
Caffeine |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
002 9件: 2 , 6 , 13, 21, 46, 78, 96, 97, 265 💬 |
244 |
Caffeine 100 mg |
Caffeine |
2件: D00528 D00528, D01453 D01453 💬 |
ADORA1 11件: ADORA1, ADORA2A, PDE1B, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE5A 💬 |
Alcoholism 22件: Alcoholism, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Olfactory transduction, Parathyroid hormone synthesis, secretion and action, Parkinson disease, Progesterone-mediated oocyte maturation, Purine metabolism, Rap1 signaling pathway, Regulation of lipolysis in adipocytes, Renin secretion, Sphingolipid signaling pathway, Taste transduction, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
245 |
Calcitonin nasal spray (salmon) |
Salmon, unspecified |
- |
- |
- |
096 2件: 96, 97 💬 |
246 |
Calcitriol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
037 8件: 37, 46, 49, 66, 96, 158, 235, 326 💬 |
247 |
Calcium |
Calcium |
- |
- |
- |
006 27件: 6 , 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬 |
248 |
Calcium carbonate |
Calcium |
2件: D00932 D00932, D10802 D10802 💬 |
- |
- |
013 8件: 13, 19, 46, 53, 75, 96, 235, 299 💬 |
249 |
Caltrate pill |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
250 |
Cannabidiol |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
006 17件: 6 , 8 , 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 226, 271 💬 |
251 |
Cannabidiol , synthetic form |
Cannabidiol |
1件: D10915 D10915 💬 |
CNR1 2件: CNR1, CNR2 💬 |
Neuroactive ligand-receptor interaction 4件: Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis |
096 1件: 96 💬 |
252 |
Cannabis |
Medical Cannabis |
- |
- |
- |
002 8件: 2 , 6 , 13, 46, 90, 96, 97, 271 💬 |
253 |
Cannabis, medical |
Medical Cannabis |
- |
- |
- |
002 5件: 2 , 6 , 13, 96, 97 💬 |
254 |
Carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
006 9件: 6 , 46, 50, 51, 85, 86, 96, 97, 298 💬 |
255 |
Carbonate |
Carbonate ion |
- |
- |
- |
002 12件: 2 , 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 💬 |
256 |
Carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
005 8件: 5 , 13, 58, 96, 97, 265, 298, 316 💬 |
257 |
Cc |
- |
- |
- |
- |
013 13件: 13, 28, 46, 49, 51, 56, 84, 85, 96, 97, 162, 202, 271 💬 |
258 |
Cc-5013 |
- |
- |
- |
- |
028 2件: 28, 96 💬 |
259 |
Ccx282-b |
- |
- |
- |
- |
096 1件: 96 💬 |
260 |
Cd |
- |
- |
- |
- |
006 6件: 6 , 46, 51, 96, 97, 265 💬 |
261 |
Cdp6038 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
262 |
Cdp870 |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
263 |
Celebrex |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
264 |
Cellulose |
Microcrystalline cellulose |
1件: D00093 D00093 💬 |
- |
- |
035 4件: 35, 53, 96, 162 💬 |
265 |
Certican |
- |
- |
- |
- |
067 4件: 67, 96, 158, 228 💬 |
266 |
Certolizumab |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
267 |
Certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 6件: 37, 46, 96, 97, 226, 271 💬 |
268 |
Certolizumab pegol (cdp870) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
269 |
Certolizumab pegol (cdp870, czp) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
270 |
Certolizumab pegol (czp) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 271 💬 |
271 |
Certolizumab pegol (rinn) |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
272 |
Certolizumab pegol /cimzia |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
273 |
Certolizumab pegol 400 mg |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
274 |
Chadox2 hav |
- |
- |
- |
- |
096 1件: 96 💬 |
275 |
Chenodeoxycholic acid |
Chenodeoxycholic acid |
1件: D00163 D00163 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
020 4件: 20, 96, 234, 263 💬 |
276 |
Chenodiol |
Chenodeoxycholic acid |
1件: D00163 D00163 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
096 1件: 96 💬 |
277 |
Chenofalk |
- |
- |
- |
- |
096 1件: 96 💬 |
278 |
Chimeric igg1 monoclonal antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
279 |
Chloride |
Chloride ion |
- |
- |
- |
006 25件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
280 |
Chlorure de sodium |
- |
- |
- |
- |
096 1件: 96 💬 |
281 |
Cholecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 9件: 13, 19, 34, 46, 49, 96, 97, 298, 299 💬 |
282 |
Cholecalciferol 10,000 iu |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
283 |
Cholecalciferol 400 iu |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
284 |
Cholecalciferol concentrate |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
285 |
Cholecalciferol concentrate (water-dispersible form) |
Cholecalciferol |
2件: D00001 D00001, D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
286 |
Cholestagel |
- |
- |
- |
- |
096 1件: 96 💬 |
287 |
Chondroitin sulfate |
Chondroitin sulfate |
1件: D00080 D00080 💬 |
- |
- |
096 2件: 96, 226 💬 |
288 |
Cimzia |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
289 |
Cimzia 200 mg solution for injection |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
290 |
Ciprofloxacin |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
002 5件: 2 , 60, 96, 97, 299 💬 |
291 |
Ciprofloxacin hydrochloride |
Ciprofloxacin |
2件: D00186 D00186, D02216 D02216 💬 |
- |
- |
096 2件: 96, 299 💬 |
292 |
Clarithromycin |
Clarithromycin |
1件: D00276 D00276 💬 |
- |
- |
006 8件: 6 , 63, 84, 96, 97, 222, 228, 299 💬 |
293 |
Clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
019 9件: 19, 20, 40, 46, 49, 60, 96, 234, 326 💬 |
294 |
Clofazimine |
Clofazimine |
1件: D00278 D00278 💬 |
- |
- |
096 1件: 96 💬 |
295 |
Cnto 1275 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
296 |
Cnto1275 |
- |
- |
- |
- |
046 6件: 46, 49, 84, 93, 96, 97 💬 |
297 |
Cnto1959 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
298 |
Coffee |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
299 |
Colecalciferol |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
013 4件: 13, 46, 96, 228 💬 |
300 |
Colecalciferol d3 (vigantol oil) |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
301 |
Colesevelam |
Colesevelam |
2件: D03582 D03582, D07743 D07743 💬 |
- |
- |
096 2件: 96, 260 💬 |
302 |
Colony-purified bacteroides thetaiotaomicron (b.theta) |
- |
- |
- |
- |
096 1件: 96 💬 |
303 |
Contrast enhanced ultrasound |
- |
- |
- |
- |
096 1件: 96 💬 |
304 |
Cortecosteroid |
- |
- |
- |
- |
096 1件: 96 💬 |
305 |
Corticosteroid |
- |
- |
- |
- |
013 10件: 13, 42, 43, 44, 45, 66, 84, 96, 97, 222 💬 |
306 |
Cosmofer |
- |
- |
- |
- |
086 3件: 86, 96, 97 💬 |
307 |
Cosmofer 50mg/ml solution for infusion or injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
308 |
Cp |
- |
- |
- |
- |
006 6件: 6 , 46, 96, 97, 107, 271 💬 |
309 |
Cp-461 |
- |
- |
- |
- |
096 1件: 96 💬 |
310 |
Cp-690,550 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
311 |
Cp-690,550-10 |
- |
- |
- |
- |
046 5件: 46, 96, 97, 107, 271 💬 |
312 |
Cpsi-2364 |
- |
- |
- |
- |
096 1件: 96 💬 |
313 |
Crohn's disease |
- |
- |
- |
- |
096 1件: 96 💬 |
314 |
Crohns disease exclusion diet + pen |
- |
- |
- |
- |
096 1件: 96 💬 |
315 |
Crown |
- |
- |
- |
- |
096 1件: 96 💬 |
316 |
Ct-p13 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
317 |
Ct-p13 sc (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
318 |
Ctla4ig |
- |
- |
- |
- |
046 4件: 46, 49, 96, 271 💬 |
319 |
Curcuma |
- |
- |
- |
- |
096 1件: 96 💬 |
320 |
Curcuma longa |
Turmeric |
- |
- |
- |
096 2件: 96, 299 💬 |
321 |
Curcuma longa rhizoma |
Turmeric |
- |
- |
- |
096 1件: 96 💬 |
322 |
Curcumin |
Curcumin |
- |
- |
- |
002 11件: 2 , 13, 46, 49, 67, 74, 94, 96, 97, 139, 299 💬 |
323 |
Cx401 |
- |
- |
- |
- |
096 1件: 96 💬 |
324 |
Cx601 |
- |
- |
- |
- |
096 1件: 96 💬 |
325 |
Cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
011 44件: 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
326 |
Cyclophosphamide monohydrate |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
013 4件: 13, 60, 96, 256 💬 |
327 |
Cyltezo |
- |
- |
- |
- |
096 1件: 96 💬 |
328 |
Cytochrome p450 (cyp) substrates |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
329 |
Cytoxan |
- |
- |
- |
- |
060 2件: 60, 96 💬 |
330 |
D-cura |
- |
- |
- |
- |
096 1件: 96 💬 |
331 |
D9421-c |
- |
- |
- |
- |
096 1件: 96 💬 |
332 |
D9421-c capsule 3 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
333 |
D9421-c, 15mg |
- |
- |
- |
- |
096 1件: 96 💬 |
334 |
D9421-c, 9mg |
- |
- |
- |
- |
096 1件: 96 💬 |
335 |
Darvadstrocel |
- |
- |
- |
- |
096 1件: 96 💬 |
336 |
Db adalimumab 40 mg eow |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
337 |
Db adalimumab 40 mg ew |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
338 |
Decortin 20 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
339 |
Decortin 5 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
340 |
Dehydroepiandrosterone |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 5件: 49, 53, 83, 96, 113 💬 |
341 |
Dehydroepiandrosterone [dhea] |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
096 1件: 96 💬 |
342 |
Dekristol 20.000 ie |
- |
- |
- |
- |
096 1件: 96 💬 |
343 |
Delayed release 6 mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 1件: 96 💬 |
344 |
Delayed release 6mp or calcitriol vs. purinethol |
Calcitriol |
1件: D00129 D00129 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
345 |
Denosumab |
Denosumab |
1件: D03684 D03684 💬 |
TNFSF11 1件: TNFSF11 💬 |
Breast cancer 7件: Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 7件: 46, 50, 93, 95, 96, 274, 299 💬 |
346 |
Device: capsule endoscopy |
- |
- |
- |
- |
096 1件: 96 💬 |
347 |
Device: cellulose |
Microcrystalline cellulose |
1件: D00093 D00093 💬 |
- |
- |
096 1件: 96 💬 |
348 |
Device: contrast enhanced ultrasound |
- |
- |
- |
- |
096 1件: 96 💬 |
349 |
Device: endopath from itamar medical - fda approved device. |
- |
- |
- |
- |
096 1件: 96 💬 |
350 |
Device: fluorescence endoscopy and spectroscopy |
- |
- |
- |
- |
096 1件: 96 💬 |
351 |
Device: magnetic resonance enterography (mre) |
- |
- |
- |
- |
096 1件: 96 💬 |
352 |
Device: pma-zeolite |
- |
- |
- |
- |
096 1件: 96 💬 |
353 |
Device: ultrasound elastography |
- |
- |
- |
- |
096 1件: 96 💬 |
354 |
Device: ultrasound imaging |
- |
- |
- |
- |
096 1件: 96 💬 |
355 |
Device: ultrasound vascularity |
- |
- |
- |
- |
096 1件: 96 💬 |
356 |
Dexametasona |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
357 |
Dexamethasone |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
013 25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
358 |
Dexamethasone sodium phosphate |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
065 3件: 65, 70, 96 💬 |
359 |
Dexamethasone sodium phosphate 250 mg/ 10 ml |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
360 |
Dextran |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
002 5件: 2 , 62, 79, 96, 97 💬 |
361 |
Dextromethorphan |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
002 11件: 2 , 6 , 8 , 13, 21, 46, 78, 85, 96, 97, 156 💬 |
362 |
Dextromethorphan 30 mg |
Dextromethorphan |
3件: D00848 D00848, D03742 D03742, D03744 D03744 💬 |
GRIN1 6件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D, SIGMAR1 💬 |
Alcoholism 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway |
096 2件: 96, 97 💬 |
363 |
Dhea |
Prasterone |
1件: D08409 D08409 💬 |
AR 3件: AR, ESR1, ESR2 💬 |
Breast cancer 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway |
049 3件: 49, 86, 96 💬 |
364 |
Diagnostic test: 18f-fdg and 68ga-fapi pet/ct |
Fludeoxyglucose (18F) |
- |
- |
- |
096 1件: 96 💬 |
365 |
Diagnostic test: serum leucine-rich alpha-2 glycoprotein (lrg) levels |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
096 2件: 96, 97 💬 |
366 |
Diet 1 |
- |
- |
- |
- |
096 1件: 96 💬 |
367 |
Diet 2 |
- |
- |
- |
- |
096 1件: 96 💬 |
368 |
Dietary therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
369 |
Diethyl-[6-(4-hydroxycarbamoyl-phenylcarbamoyloxymethyl)-naphtalen-2-ylmethyl]-ammonium chloride mon |
Ammonium chloride |
1件: D01139 D01139 💬 |
- |
- |
096 1件: 96 💬 |
370 |
Diflucan |
Fluconazole |
2件: D00322 D00322, D01429 D01429 💬 |
- |
- |
096 1件: 96 💬 |
371 |
Diphenhydramine |
Diphenhydramine |
6件: D00300 D00300, D00669 D00669, D02419 D02419, D03285 D03285, D03360 D03360, D03854 D03854 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
011 8件: 11, 49, 51, 70, 86, 96, 222, 256 💬 |
372 |
Dlx105 |
- |
- |
- |
- |
096 1件: 96 💬 |
373 |
Doxycycline |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
013 15件: 13, 23, 28, 46, 84, 85, 89, 96, 97, 158, 162, 167, 227, 280, 299 💬 |
374 |
Doxycycline hyclate |
Doxycycline |
5件: D00307 D00307, D02129 D02129, D03903 D03903, D03904 D03904, D07876 D07876 💬 |
- |
- |
023 3件: 23, 96, 227 💬 |
375 |
E-device |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
376 |
E6011 |
- |
- |
- |
- |
046 3件: 46, 93, 96 💬 |
377 |
E6011 10 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
378 |
E6011 15 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
379 |
E6011 2 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
380 |
E6011 5 mg/kg |
- |
- |
- |
- |
096 1件: 96 💬 |
381 |
Early immunosuppressants (azathioprine, methotrexate) |
Azathioprine |
4件: D00142 D00142, D00238 D00238, D02115 D02115, D03033 D03033 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 1件: 96 💬 |
382 |
Eb8018 |
- |
- |
- |
- |
096 1件: 96 💬 |
383 |
Eb8018 (first-in-class fimh blocker) |
- |
- |
- |
- |
096 1件: 96 💬 |
384 |
Een |
- |
- |
- |
- |
096 1件: 96 💬 |
385 |
Een intervention group |
- |
- |
- |
- |
096 1件: 96 💬 |
386 |
Efalizumab |
Efalizumab |
1件: D03959 D03959 💬 |
ITGAL 1件: ITGAL 💬 |
Cell adhesion molecules 12件: Cell adhesion molecules, Epstein-Barr virus infection, Human T-cell leukemia virus 1 infection, Leukocyte transendothelial migration, Malaria, Natural killer cell mediated cytotoxicity, Neutrophil extracellular trap formation, Rap1 signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Staphylococcus aureus infection, Viral myocarditis |
011 8件: 11, 13, 37, 46, 53, 61, 95, 96 💬 |
387 |
Egg |
Egg |
- |
- |
- |
096 2件: 96, 310 💬 |
388 |
Egg albumen powder |
Egg |
- |
- |
- |
096 1件: 96 💬 |
389 |
Egg white |
Egg |
- |
- |
- |
096 1件: 96 💬 |
390 |
Egg white protein |
Egg |
- |
- |
- |
096 1件: 96 💬 |
391 |
Eicosapentaenoic acid |
Icosapent |
1件: D08061 D08061 💬 |
- |
- |
049 5件: 49, 96, 97, 296, 297 💬 |
392 |
Emea/h/c/000240 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
393 |
Emea/h/c/002778 |
- |
- |
- |
- |
096 1件: 96 💬 |
394 |
Endoxan |
- |
- |
- |
- |
013 7件: 13, 28, 43, 44, 85, 96, 222 💬 |
395 |
Endoxan baxter |
- |
- |
- |
- |
013 3件: 13, 43, 96 💬 |
396 |
Entecavir |
Entecavir |
2件: D04008 D04008, D07896 D07896 💬 |
- |
- |
046 5件: 46, 56, 96, 97, 271 💬 |
397 |
Enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
398 |
Enteral nutrition. |
- |
- |
- |
- |
096 1件: 96 💬 |
399 |
Entocort |
- |
- |
- |
- |
096 1件: 96 💬 |
400 |
Entocort cr |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
401 |
Entocort® kapseln |
- |
- |
- |
- |
096 1件: 96 💬 |
402 |
Entyvio |
- |
- |
- |
- |
094 3件: 94, 96, 97 💬 |
403 |
Epanova |
- |
- |
- |
- |
096 1件: 96 💬 |
404 |
Epanova™ (omega-3 free fatty acids) |
Omega-3 fatty acids |
- |
- |
- |
096 1件: 96 💬 |
405 |
Epaxal berna (virosomal hepatitis a vaccine) |
Hepatitis A Vaccine |
- |
- |
- |
096 2件: 96, 97 💬 |
406 |
Epinephrine |
Epinephrine |
3件: D00095 D00095, D00996 D00996, D02149 D02149 💬 |
ADRA1A 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 |
AMPK signaling pathway 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
046 2件: 46, 96 💬 |
407 |
Erb-041 |
- |
- |
- |
- |
046 3件: 46, 96, 226 💬 |
408 |
Ergocalciferol |
Ergocalciferol |
1件: D00187 D00187 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
046 5件: 46, 84, 96, 97, 299 💬 |
409 |
Ery-dex |
- |
- |
- |
- |
096 1件: 96 💬 |
410 |
Erythropoietin |
Erythropoietin |
1件: D03231 D03231 💬 |
EPOR 1件: EPOR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 9件: 2 , 6 , 13, 18, 22, 47, 70, 95, 96 💬 |
411 |
Eskazole |
Albendazole |
1件: D00134 D00134 💬 |
- |
- |
096 1件: 96 💬 |
412 |
Etiprednol dicloacetate |
Etiprednol dicloacetate |
1件: D04100 D04100 💬 |
- |
- |
096 1件: 96 💬 |
413 |
Etrasimod |
Etrasimod |
1件: D10930 D10930 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97 💬 |
414 |
Etrasimod l-arginine |
Arginine |
2件: D02982 D02982, D10930 D10930 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 2件: 96, 97 💬 |
415 |
Etrolizumab |
Etrolizumab |
1件: D09901 D09901 💬 |
ITGB7 1件: ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 11件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer |
096 2件: 96, 97 💬 |
416 |
Eu/1/03/268/002 |
- |
- |
- |
- |
096 1件: 96 💬 |
417 |
Eu/1/99/116/003 |
- |
- |
- |
- |
096 1件: 96 💬 |
418 |
Evaluation of biological predictive factors of clinical response to ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
419 |
Everolimus |
Everolimus |
1件: D02714 D02714 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
034 9件: 34, 67, 89, 96, 137, 157, 158, 228, 277 💬 |
420 |
Exclusive enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
421 |
Exclusive enteral nutrition therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
422 |
Expanded allogenic adipose-derived adult stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
423 |
Expanded autologous adipose-derived adult stem cells (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
424 |
Expanded human allogenic mesemchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
425 |
Expanded human allogenic mesenchymal adult stem cells extractd from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
426 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue |
- |
- |
- |
- |
096 1件: 96 💬 |
427 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs |
- |
- |
- |
- |
096 1件: 96 💬 |
428 |
Expanded human allogenic mesenchymal adult stem cells extracted from adipose tissue (eascs) |
- |
- |
- |
- |
096 1件: 96 💬 |
429 |
Faecal microbiota transplantation |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
430 |
Fe 999301 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
431 |
Fecal microbial transplant |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
432 |
Fecal microbial transplantation |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
433 |
Fecal microbiota |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
434 |
Fecal microbiota transplant |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
435 |
Fecal microbiota transplant (fmt) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
436 |
Fecal microbiota transplantation |
- |
- |
- |
- |
002 5件: 2 , 66, 94, 96, 97 💬 |
437 |
Fecal microbiota transplantation (fmt) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
438 |
Ferric carboxy maltose |
Maltose |
1件: D00044 D00044 💬 |
- |
- |
096 1件: 96 💬 |
439 |
Ferric carboxymaltose |
Ferric carboxymaltose |
1件: D08920 D08920 💬 |
- |
- |
086 4件: 86, 96, 97, 299 💬 |
440 |
Ferric maltol |
Ferric maltol |
1件: D10833 D10833 💬 |
- |
- |
096 1件: 96 💬 |
441 |
Ferrous sulphate |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
442 |
Ffp104 |
- |
- |
- |
- |
093 2件: 93, 96 💬 |
443 |
Filgotinib |
Filgotinib |
1件: D10871 D10871 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
046 6件: 46, 53, 96, 97, 222, 271 💬 |
444 |
Filgrastim |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 27件: 2 , 6 , 13, 25, 26, 28, 34, 35, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 |
445 |
Fish oil |
Fish oil |
- |
- |
- |
013 7件: 13, 46, 49, 66, 96, 260, 299 💬 |
446 |
Fitc-adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
447 |
Flagyl |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
448 |
Flixabi |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
449 |
Fluconazole |
Fluconazole |
2件: D00322 D00322, D01429 D01429 💬 |
- |
- |
096 2件: 96, 225 💬 |
450 |
Fludarabine |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
013 17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 💬 |
451 |
Fludarabine phosphate |
Fludarabine |
2件: D01907 D01907, D07966 D07966 💬 |
RRM1 1件: RRM1 💬 |
Drug metabolism - other enzymes 5件: Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
028 11件: 28, 36, 49, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
452 |
Fmt |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
453 |
Folatescan (technetium tc 99mec20) |
- |
- |
- |
- |
013 4件: 13, 46, 49, 96 💬 |
454 |
Fos |
- |
- |
- |
- |
066 2件: 66, 96 💬 |
455 |
Fosfato sodico de dexametasona |
Dexamethasone |
9件: D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
456 |
Fosfomycin |
Fosfomycin |
4件: D00925 D00925, D02187 D02187, D02188 D02188, D04253 D04253 💬 |
- |
- |
096 2件: 96, 97 💬 |
457 |
Fully humanised, recombinant monoclonal antibody (igg1) |
- |
- |
- |
- |
096 1件: 96 💬 |
458 |
G-csf |
Filgrastim |
1件: D03235 D03235 💬 |
CSF3R 1件: CSF3R 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer |
002 16件: 2 , 6 , 11, 13, 16, 47, 49, 51, 60, 62, 65, 85, 96, 284, 285, 331 💬 |
459 |
G321605 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
460 |
Ged-0301 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
461 |
Genetic: genetic analysis |
- |
- |
- |
- |
096 1件: 96 💬 |
462 |
Genetic: tpmt genotyping |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
463 |
Glatiramer |
Glatiramer |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
002 4件: 2 , 13, 96, 156 💬 |
464 |
Glatiramer acetate |
Acetate |
1件: D04318 D04318 💬 |
HLA-A 20件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G 💬 |
Allograft rejection 32件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis |
013 3件: 13, 96, 156 💬 |
465 |
Glpg0634 |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
466 |
Glpg1205 |
- |
- |
- |
- |
085 3件: 85, 96, 97 💬 |
467 |
Glucose |
Dextrose, unspecified form |
- |
- |
- |
002 15件: 2 , 6 , 13, 49, 50, 65, 75, 86, 88, 96, 160, 195, 254, 257, 299 💬 |
468 |
Glutamine |
L-Glutamine |
1件: D00015 D00015 💬 |
- |
- |
087 7件: 87, 89, 96, 97, 113, 245, 299 💬 |
469 |
Gold |
Gold |
- |
- |
- |
002 38件: 2 , 5 , 6 , 13, 17, 34, 46, 49, 50, 53, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 158, 162, 171, 218, 222, 224, 227, 230, 271, 291, 294, 296, 298, 299, 310, 318 💬 |
470 |
Golimumab |
Golimumab |
1件: D04358 D04358 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 6件: 46, 56, 84, 96, 97, 271 💬 |
471 |
Green tea |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
006 5件: 6 , 17, 28, 46, 96 💬 |
472 |
Group 2 ustekinumab 130 mg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
473 |
Group 3: ustekinumab approximately 6 mg/kg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
474 |
Growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 12件: 2 , 13, 19, 46, 78, 96, 187, 191, 193, 195, 265, 299 💬 |
475 |
Gs-5745 |
GS-5745 |
- |
- |
- |
046 4件: 46, 96, 97, 299 💬 |
476 |
Gs-6034 |
- |
- |
- |
- |
046 4件: 46, 53, 96, 97 💬 |
477 |
Gsk1070806 |
- |
- |
- |
- |
056 2件: 56, 96 💬 |
478 |
Gsk1605786 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
479 |
Gsk1605786 500 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
480 |
Gsk1605786 capsule |
- |
- |
- |
- |
096 1件: 96 💬 |
481 |
Gsk1605786 chemocentryx: formulation a |
- |
- |
- |
- |
096 1件: 96 💬 |
482 |
Gsk1605786 gsk direct-fill: formulation c |
- |
- |
- |
- |
096 1件: 96 💬 |
483 |
Gsk1605786 gsk modified-process: formulation d |
- |
- |
- |
- |
096 1件: 96 💬 |
484 |
Gsk1605786 gsk tablet: formulation e |
- |
- |
- |
- |
096 1件: 96 💬 |
485 |
Gsk1605786 gsk: formulation b |
- |
- |
- |
- |
096 1件: 96 💬 |
486 |
Gsk1605786a |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
487 |
Gsk2330811 |
- |
- |
- |
- |
051 2件: 51, 96 💬 |
488 |
Guselkumab |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 41, 96, 97 💬 |
489 |
Guselkumab dose 1 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
490 |
Guselkumab dose 2 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
491 |
Guselkumab dose 3 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
492 |
Guselkumab dose 4 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
493 |
Guselkumab dose 5 |
Guselkumab |
1件: D10438 D10438 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
494 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 12件: 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
495 |
Hepatitis a vaccine |
Hepatitis A Vaccine |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
496 |
Herpes zoster vaccine |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
497 |
Hextend |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
498 |
High dose tso |
- |
- |
- |
- |
096 1件: 96 💬 |
499 |
High oligosaccharide group |
- |
- |
- |
- |
096 1件: 96 💬 |
500 |
High-dose cyclophosphamide |
Cyclophosphamide |
2件: D00287 D00287, D07760 D07760 💬 |
- |
- |
096 1件: 96 💬 |
501 |
Hmpl-004 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
502 |
Hmpl004-6599 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
503 |
Hulio |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
504 |
Hum291 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
505 |
Human albumin |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
002 2件: 2 , 96 💬 |
506 |
Human albumin as macroaggregates |
Albumin human |
2件: D02792 D02792, D05424 D05424 💬 |
- |
- |
096 1件: 96 💬 |
507 |
Human anti-il-12 antibody |
- |
- |
- |
- |
096 1件: 96 💬 |
508 |
Human anti-ip10 monoclonal antibody |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
509 |
Human insulin |
Insulin human |
2件: D00085 D00085, D03230 D03230 💬 |
INSR 1件: INSR 💬 |
AMPK signaling pathway 22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway |
096 2件: 96, 156 💬 |
510 |
Human monoclonal antibody (cnto 1275) to interleukin 12p-40 |
- |
- |
- |
- |
096 1件: 96 💬 |
511 |
Human placenta-derived cells pda001 intravenous infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
512 |
Human plasma for fractionation |
- |
- |
- |
- |
096 1件: 96 💬 |
513 |
Humira |
- |
- |
- |
- |
046 7件: 46, 84, 96, 97, 160, 269, 271 💬 |
514 |
Humira (adalimumab original) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
515 |
Humira (adalimumab) |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
516 |
Humira 20 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 1件: 96 💬 |
517 |
Humira 40 mg injekcní roztok v predplnené injekcní stríkacce |
- |
- |
- |
- |
096 1件: 96 💬 |
518 |
Humira 40 mg solución inyectable en jeringa precargada |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
519 |
Humira 40 mg solution for injection in pre-filled pen |
- |
- |
- |
- |
096 1件: 96 💬 |
520 |
Humira 40 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
521 |
Humira 40 mg/0.8 ml solution for injection |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
522 |
Humira 40mg solution for injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
523 |
Humira 40mg/0.4ml pre-filled syringe |
- |
- |
- |
- |
096 1件: 96 💬 |
524 |
Humira 40mg/0.8ml solution for injection for paediatric use |
- |
- |
- |
- |
096 1件: 96 💬 |
525 |
Humira pre-filled pen |
- |
- |
- |
- |
096 1件: 96 💬 |
526 |
Humira ® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
527 |
Humira*sc 2sir+f 40mg 0,8ml+2t |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
528 |
Humira® |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
529 |
Hydroxide |
Hydroxide ion |
- |
- |
- |
046 4件: 46, 96, 97, 284 💬 |
530 |
Hydroxychloroquine |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
013 23件: 13, 34, 41, 43, 44, 45, 46, 48, 49, 53, 56, 66, 84, 89, 90, 96, 218, 222, 234, 254, 271, 298, 299 💬 |
531 |
Hydroxychloroquine sulphate |
Hydroxychloroquine |
1件: D08050 D08050 💬 |
- |
- |
096 1件: 96 💬 |
532 |
Igg2 antibodies |
- |
- |
- |
- |
096 1件: 96 💬 |
533 |
Il-2 |
Human interleukin-2 |
- |
- |
- |
002 6件: 2 , 46, 49, 53, 56, 96 💬 |
534 |
Im90838 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
535 |
Immune ablation and hematopoietic stem cell support |
- |
- |
- |
- |
096 1件: 96 💬 |
536 |
Immunonutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
537 |
Immunosuppressor/tnfalpha |
- |
- |
- |
- |
096 1件: 96 💬 |
538 |
Imp will be labeled as ''pf-04236921 106mg/vial, clonal sc lyophilized form''. |
- |
- |
- |
- |
096 1件: 96 💬 |
539 |
Imp will be labeled as pf-04236921 106mg/vial, clonal sc lyophilized form |
- |
- |
- |
- |
096 1件: 96 💬 |
540 |
Impact |
- |
- |
- |
- |
006 8件: 6 , 13, 46, 50, 53, 96, 97, 299 💬 |
541 |
Imraldi |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
542 |
Imu-838 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
543 |
Imuran |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
544 |
Imurel |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97 💬 |
545 |
Imurel 25 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
546 |
Increlex |
- |
- |
- |
- |
065 4件: 65, 78, 96, 299 💬 |
547 |
Increlex 10mg/ml solution for injection |
- |
- |
- |
- |
096 1件: 96 💬 |
548 |
Indocyanine green |
Indocyanine green |
1件: D01342 D01342 💬 |
- |
- |
046 7件: 46, 51, 96, 235, 278, 291, 296 💬 |
549 |
Inflectra |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
550 |
Inflectra 100 mg powder for concentrate for solution for infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
551 |
Infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
035 24件: 35, 37, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 55, 56, 65, 84, 95, 96, 97, 98, 162, 164, 269, 271 💬 |
552 |
Infliximab (ifx alone) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
553 |
Infliximab (remicade) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 271 💬 |
554 |
Infliximab (remicade): 100 mg of lyophilized infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
555 |
Infliximab 10 mg/kg |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
556 |
Infliximab 20 mg/kg |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
557 |
Infliximab 5 mg/kg |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
558 |
Infliximab 5 mg/kg body weight infused over 2 hours |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
559 |
Infliximab 5 mg/kg every 6 weeks |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
560 |
Infliximab 7 mg/kg every 8 weeks |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
561 |
Infliximab [infliximab biosimilar 3] |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
037 4件: 37, 46, 96, 97 💬 |
562 |
Infliximab and adalimumab |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
563 |
Infliximab and azathioprine combination at week 0 |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
564 |
Infliximab and azathioprine combination at week 14 |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
565 |
Infliximab infusion |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
566 |
Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab |
Adalimumab |
5件: D02597 D02597, D02598 D02598, D04358 D04358, D08083 D08083, D09214 D09214 💬 |
IL12A 6件: IL12A, IL12B, IL23A, ITGA4, ITGB7, TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 79件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Arrhythmogenic right ventricular cardiomyopathy, Asthma, C-type lectin receptor signaling pathway, Cell adhesion molecules, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, ECM-receptor interaction, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Focal adhesion, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Leukocyte transendothelial migration, MAPK signaling pathway, Malaria, Measles, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathogenic Escherichia coli infection, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Regulation of actin cytoskeleton, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Transcriptional misregulation in cancer, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
567 |
Infliximab with azathioprine (iifx + aza) |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
568 |
Infliximab+azathioprine |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
569 |
Infliximab, adalimumab, certolizumab pegol |
Adalimumab |
3件: D02597 D02597, D02598 D02598, D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
570 |
Infliximab, azathioprine |
Azathioprine |
3件: D00238 D00238, D02598 D02598, D03033 D03033 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
571 |
Infliximab-biosimilar |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
572 |
Infliximab-innovator |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
573 |
Injection of iron |
- |
- |
- |
- |
096 1件: 96 💬 |
574 |
Innovator infliximab |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
575 |
Inositol |
Inositol |
1件: D08079 D08079 💬 |
- |
- |
096 2件: 96, 97 💬 |
576 |
Interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
025 5件: 25, 26, 28, 56, 96 💬 |
577 |
Interferon beta |
Human interferon beta |
- |
- |
- |
013 5件: 13, 20, 26, 96, 97 💬 |
578 |
Interferon beta-1a |
Human interferon beta |
1件: D04554 D04554 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 4件: 13, 26, 96, 97 💬 |
579 |
Interleukin 2 |
- |
- |
- |
- |
046 9件: 46, 49, 51, 56, 63, 95, 96, 97, 271 💬 |
580 |
Interleukin-11 |
Oprelvekin |
1件: D05266 D05266 💬 |
IL11RA 1件: IL11RA 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
096 2件: 96, 288 💬 |
581 |
Interleukin-2 |
Human interleukin-2 |
- |
- |
- |
002 8件: 2 , 35, 49, 55, 65, 96, 97, 162 💬 |
582 |
Interleukin-2 (aldesleukin). |
Aldesleukin |
1件: D00748 D00748 💬 |
IL2RA 3件: IL2RA, IL2RB, IL2RG 💬 |
Cytokine-cytokine receptor interaction 14件: Cytokine-cytokine receptor interaction, Endocytosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Inflammatory bowel disease, JAK-STAT signaling pathway, Measles, PI3K-Akt signaling pathway, Pathways in cancer, Primary immunodeficiency, Th1 and Th2 cell differentiation, Th17 cell differentiation, Transcriptional misregulation in cancer, Viral protein interaction with cytokine and cytokine receptor |
096 2件: 96, 97 💬 |
583 |
Intralipid |
- |
- |
- |
- |
096 1件: 96 💬 |
584 |
Intralipid 10% |
- |
- |
- |
- |
096 1件: 96 💬 |
585 |
Intralipid 20% |
- |
- |
- |
- |
096 1件: 96 💬 |
586 |
Inulin |
Inulin |
1件: D00171 D00171 💬 |
- |
- |
096 2件: 96, 299 💬 |
587 |
Invita d3 |
- |
- |
- |
- |
096 1件: 96 💬 |
588 |
Iron |
Iron |
- |
- |
- |
018 5件: 18, 96, 97, 254, 284 💬 |
589 |
Iron sucrose |
Iron |
2件: D00025 D00025, D04616 D04616 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
590 |
Iron sulphate |
Iron |
- |
- |
- |
096 2件: 96, 97 💬 |
591 |
Iron sulphate 200mg coated tablets |
Iron |
- |
- |
- |
096 2件: 96, 97 💬 |
592 |
Iron supplement 300-600 mg/day |
Iron |
- |
- |
- |
096 2件: 96, 97 💬 |
593 |
Iron(iii)- hydroxide dextran complex |
Dextran |
1件: D00060 D00060 💬 |
- |
- |
096 2件: 96, 97 💬 |
594 |
Itf 2357 |
- |
- |
- |
- |
096 1件: 96 💬 |
595 |
Itf2357 |
- |
- |
- |
- |
096 4件: 96, 107, 113, 267 💬 |
596 |
J695 |
- |
- |
- |
- |
096 1件: 96 💬 |
597 |
J695, bsf 415977 (formerly lu415977), way-165772, a-796874.0 |
- |
- |
- |
- |
096 1件: 96 💬 |
598 |
Jnj-40346527 |
JNJ-40346527 |
- |
- |
- |
046 2件: 46, 96 💬 |
599 |
Jnj-40346527-aac |
JNJ-40346527 |
- |
- |
- |
096 1件: 96 💬 |
600 |
Jnj-64304500 |
- |
- |
- |
- |
096 1件: 96 💬 |
601 |
Jnj-64304500-aaa |
- |
- |
- |
- |
096 1件: 96 💬 |
602 |
Jnj-67864238 |
- |
- |
- |
- |
096 1件: 96 💬 |
603 |
Kanamycin |
Kanamycin |
3件: D00866 D00866, D03262 D03262, D07497 D07497 💬 |
- |
- |
096 2件: 96, 291 💬 |
604 |
Kenacort |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
605 |
Kremezin |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
606 |
Kremezin®, spherical adsorptive carbon |
Activated charcoal |
1件: D03251 D03251 💬 |
- |
- |
096 2件: 96, 97 💬 |
607 |
L 44 |
- |
- |
- |
- |
096 1件: 96 💬 |
608 |
L-carnitine |
Levocarnitine |
3件: D02030 D02030, D02176 D02176, D04713 D04713 💬 |
- |
- |
013 6件: 13, 96, 97, 265, 298, 316 💬 |
609 |
L01ba |
- |
- |
- |
- |
096 1件: 96 💬 |
610 |
Lactated ringers |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
611 |
Lactobacillus salivarius ucc118 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
612 |
Lactulose |
Lactulose |
1件: D00352 D00352 💬 |
- |
- |
096 2件: 96, 291 💬 |
613 |
Lactulose/rhamnose solution |
Lactulose |
1件: D00352 D00352 💬 |
- |
- |
096 1件: 96 💬 |
614 |
Lap tap bupivacaine/epinephrine |
Bupivacaine |
5件: D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
615 |
Laquinimod |
Laquinimod |
- |
- |
- |
008 4件: 8 , 13, 49, 96 💬 |
616 |
Laquinimod capsules 0.5 mg |
Laquinimod |
- |
- |
- |
008 2件: 8 , 96 💬 |
617 |
Laquinimod cápsulas 0.5 mg |
Laquinimod |
- |
- |
- |
096 1件: 96 💬 |
618 |
Ldp-02 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
619 |
Leucine |
Leucine |
1件: D00030 D00030 💬 |
- |
- |
005 10件: 5 , 6 , 7 , 19, 96, 97, 127, 283, 284, 299 💬 |
620 |
Lipitor |
- |
- |
- |
- |
051 3件: 51, 96, 299 💬 |
621 |
Liposomal bupivacaine |
Bupivacaine |
2件: D01450 D01450, D07552 D07552 💬 |
SCN1A 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
Adrenergic signaling in cardiomyocytes 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction |
051 3件: 51, 70, 96 💬 |
622 |
Losartan |
Losartan |
2件: D00357 D00357, D08146 D08146 💬 |
AGTR1 1件: AGTR1 💬 |
AGE-RAGE signaling pathway in diabetic complications 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway |
017 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬 |
623 |
Low dose naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 2件: 96, 97 💬 |
624 |
Low dose tso |
- |
- |
- |
- |
096 1件: 96 💬 |
625 |
Low-dose il-2 administration |
Human interleukin-2 |
- |
- |
- |
096 1件: 96 💬 |
626 |
Lumbar puncture |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
627 |
Lumentin 44 |
- |
- |
- |
- |
096 1件: 96 💬 |
628 |
Ly3074828 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
629 |
Lymphocyte immune globulin |
- |
- |
- |
- |
096 1件: 96 💬 |
630 |
Maltodextrin |
Maltodextrin |
1件: D02329 D02329 💬 |
- |
- |
006 4件: 6 , 13, 96, 97 💬 |
631 |
Maltose |
Maltose |
1件: D00044 D00044 💬 |
- |
- |
096 2件: 96, 97 💬 |
632 |
Mango |
Mango |
- |
- |
- |
096 2件: 96, 97 💬 |
633 |
Mango polyphenolics |
Mango |
- |
- |
- |
096 2件: 96, 97 💬 |
634 |
Mannitol |
Mannitol |
1件: D00062 D00062 💬 |
- |
- |
006 4件: 6 , 60, 96, 299 💬 |
635 |
Mare´s milk |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
636 |
Masitinib |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
637 |
Masitinib mesylate |
Masitinib |
1件: D10229 D10229 💬 |
KIT 1件: KIT 💬 |
Acute myeloid leukemia 11件: Acute myeloid leukemia, Breast cancer, Central carbon metabolism in cancer, Hematopoietic cell lineage, MAPK signaling pathway, Melanogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway |
002 6件: 2 , 5 , 6 , 13, 46, 96 💬 |
638 |
Mb-102 |
- |
- |
- |
- |
096 1件: 96 💬 |
639 |
Mdgn-002 |
- |
- |
- |
- |
096 1件: 96 💬 |
640 |
Mdx-1100 |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
641 |
Mecasermin |
Mecasermin |
2件: D03297 D03297, D04870 D04870 💬 |
GHR 2件: GHR, IGF1R 💬 |
AMPK signaling pathway 33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
078 5件: 78, 96, 168, 265, 299 💬 |
642 |
Mecasermin [rdna origin] 10mg/ml solution |
Mecasermin |
2件: D03297 D03297, D04870 D04870 💬 |
GHR 2件: GHR, IGF1R 💬 |
AMPK signaling pathway 33件: AMPK signaling pathway, Adherens junction, Autophagy - animal, Breast cancer, Cytokine-cytokine receptor interaction, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, Endocytosis, Focal adhesion, FoxO signaling pathway, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, JAK-STAT signaling pathway, Long-term depression, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Melanoma, Neuroactive ligand-receptor interaction, Oocyte meiosis, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Pathways in cancer, Progesterone-mediated oocyte maturation, Prostate cancer, Proteoglycans in cancer, Rap1 signaling pathway, Ras signaling pathway, Signaling pathways regulating pluripotency of stem cells, Transcriptional misregulation in cancer, mTOR signaling pathway |
096 1件: 96 💬 |
643 |
Medi2070 |
- |
- |
- |
- |
096 1件: 96 💬 |
644 |
Medium chain triglycerides |
- |
- |
- |
- |
096 1件: 96 💬 |
645 |
Medium dose tso |
- |
- |
- |
- |
096 1件: 96 💬 |
646 |
Melphalan |
Melphalan |
1件: D00369 D00369 💬 |
- |
- |
011 15件: 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
647 |
Mensa |
- |
- |
- |
- |
096 1件: 96 💬 |
648 |
Mercaptopurine |
Mercaptopurine |
2件: D00161 D00161, D04931 D04931 💬 |
HPRT1 1件: HPRT1 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
096 3件: 96, 97, 164 💬 |
649 |
Mesalamine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 3件: 96, 97, 164 💬 |
650 |
Mesalamine, 5-aminosalicylic acid |
Aminosalicylic acid |
2件: D00162 D00162, D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
651 |
Mesalazine |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
046 3件: 46, 96, 97 💬 |
652 |
Mesalazine (mesalamine) |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
653 |
Mesalazine ec 500 mg |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
654 |
Mesalazine sustained-release tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
655 |
Mesalazine tablets |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
656 |
Mesalazine, tripterygium glycosides |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
657 |
Mesenchymal cell and fibroblast injection |
- |
- |
- |
- |
096 1件: 96 💬 |
658 |
Mesenchymal cell transplantation |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
659 |
Mesenchymal stem cells |
- |
- |
- |
- |
002 11件: 2 , 6 , 13, 20, 49, 51, 60, 96, 222, 274, 299 💬 |
660 |
Mesenchymal stem cells (msc) |
- |
- |
- |
- |
096 1件: 96 💬 |
661 |
Mesenchymal stem cells (mscs) |
- |
- |
- |
- |
013 3件: 13, 36, 96 💬 |
662 |
Mesenchymal stromal cells |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
002 9件: 2 , 36, 49, 51, 60, 96, 97, 274, 284 💬 |
663 |
Mesenchymal stromal cells (msc) for infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 1件: 96 💬 |
664 |
Mesna |
- |
- |
- |
- |
011 11件: 11, 13, 44, 45, 49, 51, 60, 65, 85, 96, 164 💬 |
665 |
Methacholine |
Methacholine |
- |
- |
- |
096 1件: 96 💬 |
666 |
Methotrexat |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
013 4件: 13, 46, 50, 96 💬 |
667 |
Methotrexate |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
011 35件: 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 55, 56, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 271, 284, 285, 326, 331 💬 |
668 |
Methotrexate disodium |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
046 3件: 46, 96, 97 💬 |
669 |
Methotrexate injection |
Methotrexate |
2件: D00142 D00142, D02115 D02115 💬 |
DHFR 2件: DHFR, DHFR2 💬 |
Antifolate resistance 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate |
096 2件: 96, 97 💬 |
670 |
Methoxsalen |
Methoxsalen |
1件: D00139 D00139 💬 |
- |
- |
036 3件: 36, 46, 96 💬 |
671 |
Methoxsalen +ecp |
Methoxsalen |
1件: D00139 D00139 💬 |
- |
- |
096 1件: 96 💬 |
672 |
Methyl prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
043 3件: 43, 49, 96 💬 |
673 |
Methylprednisolone |
Methylprednisolone |
6件: D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 44件: 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
674 |
Methylprednisolone or budesonide |
Budesonide |
7件: D00246 D00246, D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
675 |
Metoject |
- |
- |
- |
- |
041 4件: 41, 46, 96, 97 💬 |
676 |
Metotrexat |
- |
- |
- |
- |
050 2件: 50, 96 💬 |
677 |
Metronidazol |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 2件: 46, 96 💬 |
678 |
Metronidazole |
Metronidazole |
3件: D00409 D00409, D05016 D05016, D05017 D05017 💬 |
- |
- |
046 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬 |
679 |
Microbiota |
- |
- |
- |
- |
096 1件: 96 💬 |
680 |
Midazolam |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
002 11件: 2 , 3 , 6 , 13, 21, 46, 70, 96, 97, 231, 298 💬 |
681 |
Midazolam 2 mg |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
096 2件: 96, 97 💬 |
682 |
Midazolam 3 mg |
Midazolam |
3件: D00550 D00550, D00696 D00696, D05028 D05028 💬 |
GABRA1 16件: GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 |
GABAergic synapse 7件: GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction |
096 1件: 96 💬 |
683 |
Mirikizumab |
Mirikizumab |
1件: D11123 D11123 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 3件: 37, 96, 97 💬 |
684 |
Mln0002 |
- |
- |
- |
- |
094 3件: 94, 96, 97 💬 |
685 |
Mln0002 (vedolizumab) |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
686 |
Mln0002 sc |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
687 |
Mln002 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
688 |
Mobilization of stem cells to prepare for leukapheresis |
- |
- |
- |
- |
096 1件: 96 💬 |
689 |
Moderate oligosaccharide group |
- |
- |
- |
- |
096 1件: 96 💬 |
690 |
Modulen |
- |
- |
- |
- |
096 1件: 96 💬 |
691 |
Modulen ibd |
- |
- |
- |
- |
096 1件: 96 💬 |
692 |
Modulen ibd (r) (specific enteral nutrition) |
- |
- |
- |
- |
096 1件: 96 💬 |
693 |
Mongersen |
Mongersen |
1件: D10956 D10956 💬 |
SMAD7 1件: SMAD7 💬 |
Hippo signaling pathway 2件: Hippo signaling pathway, TGF-beta signaling pathway |
096 2件: 96, 97 💬 |
694 |
Monoclonal antibodies |
- |
- |
- |
- |
096 1件: 96 💬 |
695 |
Monoclonal antibody anti-igg1 |
- |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
696 |
Monoclonal antibody ca2 |
- |
- |
- |
- |
096 1件: 96 💬 |
697 |
Mosapride |
Mosapride |
1件: D08236 D08236 💬 |
HTR4 1件: HTR4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
096 1件: 96 💬 |
698 |
Movprep |
- |
- |
- |
- |
096 1件: 96 💬 |
699 |
Msc |
- |
- |
- |
- |
006 6件: 6 , 51, 60, 96, 97, 271 💬 |
700 |
Msc injection 01 |
- |
- |
- |
- |
096 1件: 96 💬 |
701 |
Msc injection 02 |
- |
- |
- |
- |
096 1件: 96 💬 |
702 |
Msc treatment 01 |
- |
- |
- |
- |
096 1件: 96 💬 |
703 |
Msc treatment 02 |
- |
- |
- |
- |
096 1件: 96 💬 |
704 |
Msc-afp |
- |
- |
- |
- |
096 1件: 96 💬 |
705 |
Mt-1303 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
706 |
Mtx |
- |
- |
- |
- |
035 12件: 35, 40, 46, 49, 50, 60, 84, 96, 97, 107, 162, 271 💬 |
707 |
Mva |
- |
- |
- |
- |
096 1件: 96 💬 |
708 |
Mva hav |
- |
- |
- |
- |
096 1件: 96 💬 |
709 |
Mycodigest supplement |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
710 |
Mycophenolate |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 34件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬 |
711 |
Mycophenolate mofetil |
Mycophenolate mofetil |
4件: D00752 D00752, D05094 D05094, D05095 D05095, D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
002 32件: 2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 85, 93, 95, 96, 162, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬 |
712 |
Mycophenolic acid |
Mycophenolic acid |
1件: D05096 D05096 💬 |
IMPDH1 2件: IMPDH1, IMPDH2 💬 |
Drug metabolism - other enzymes 3件: Drug metabolism - other enzymes, Metabolic pathways, Purine metabolism |
011 8件: 11, 43, 49, 51, 60, 66, 96, 222 💬 |
713 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamide, sodium |
- |
- |
- |
- |
096 1件: 96 💬 |
714 |
N-{4-chloro-2-[(1-oxido-4-pyridinyl)carbonyl]phenyl}-4-(1,1-dimethylethyl)benzenesulfonamidesodium |
- |
- |
- |
- |
096 1件: 96 💬 |
715 |
N.a. |
- |
- |
- |
- |
003 10件: 3 , 6 , 8 , 13, 46, 96, 97, 240, 256, 271 💬 |
716 |
Naltrexone |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
006 12件: 6 , 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬 |
717 |
Naltrexone hydrochloride |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
010 8件: 10, 40, 41, 42, 43, 44, 45, 96 💬 |
718 |
Naltrexone-hcl |
Naltrexone |
2件: D02095 D02095, D05113 D05113 💬 |
OPRD1 3件: OPRD1, OPRK1, OPRM1 💬 |
Estrogen signaling pathway 5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
719 |
Nap |
- |
- |
- |
- |
096 2件: 96, 240 💬 |
720 |
Natalizumab |
Natalizumab |
1件: D06886 D06886 💬 |
ITGA4 1件: ITGA4 💬 |
Arrhythmogenic right ventricular cardiomyopathy 14件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Yersinia infection |
013 4件: 13, 15, 46, 96 💬 |
721 |
Neomycin |
Neomycin |
1件: D08260 D08260 💬 |
- |
- |
096 3件: 96, 97, 296 💬 |
722 |
Nessuno |
- |
- |
- |
- |
096 1件: 96 💬 |
723 |
Ni-0401 (anti-cd3 mab) |
Muromonab |
1件: D05092 D05092 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 1件: 96 💬 |
724 |
Nitazoxanide |
Nitazoxanide |
1件: D02486 D02486 💬 |
- |
- |
096 2件: 96, 97 💬 |
725 |
Nivolumab |
Nivolumab |
1件: D10316 D10316 💬 |
PDCD1 1件: PDCD1 💬 |
Cell adhesion molecules 3件: Cell adhesion molecules, PD-L1 expression and PD-1 checkpoint pathway in cancer, T cell receptor signaling pathway |
013 12件: 13, 26, 41, 46, 49, 50, 51, 53, 85, 96, 97, 159 💬 |
726 |
Nnc 0142-0000-0002 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
727 |
Nnc0114-0006 |
- |
- |
- |
- |
046 3件: 46, 49, 96 💬 |
728 |
Nnc0142-0000-0002 |
- |
- |
- |
- |
096 1件: 96 💬 |
729 |
Nnc142-0002 |
- |
- |
- |
- |
096 1件: 96 💬 |
730 |
None |
- |
- |
- |
- |
046 14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬 |
731 |
None at this time |
- |
- |
- |
- |
096 2件: 96, 140 💬 |
732 |
Normal saline |
- |
- |
- |
- |
006 16件: 6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬 |
733 |
Normix |
- |
- |
- |
- |
096 1件: 96 💬 |
734 |
Normix*ad 12cpr riv 200mg |
- |
- |
- |
- |
096 1件: 96 💬 |
735 |
Nsp001 |
- |
- |
- |
- |
096 1件: 96 💬 |
736 |
Null |
- |
- |
- |
- |
006 16件: 6 , 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 💬 |
737 |
Nutraceutical combination |
- |
- |
- |
- |
096 1件: 96 💬 |
738 |
Nutrition treat |
- |
- |
- |
- |
096 1件: 96 💬 |
739 |
Nutritional dietary intervention |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
740 |
Nutropinaq 10mg/2ml solution for injection |
- |
- |
- |
- |
096 1件: 96 💬 |
741 |
Nutropinaq® |
- |
- |
- |
- |
096 1件: 96 💬 |
742 |
Ol adalimumab 40 mg |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
743 |
Oligofructose enriched inulin |
Inulin |
1件: D00171 D00171 💬 |
- |
- |
096 1件: 96 💬 |
744 |
Olokizumab |
Olokizumab |
- |
- |
- |
046 2件: 46, 96 💬 |
745 |
Olokizumab (okz) |
Olokizumab |
- |
- |
- |
096 1件: 96 💬 |
746 |
Omega-3 |
Omega-3 fatty acids |
- |
- |
- |
013 7件: 13, 46, 49, 66, 79, 96, 299 💬 |
747 |
Omegaven |
- |
- |
- |
- |
096 1件: 96 💬 |
748 |
Omegaven 10% |
- |
- |
- |
- |
096 1件: 96 💬 |
749 |
Omeprazole |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
006 16件: 6 , 8 , 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299 💬 |
750 |
Omeprazole 20 mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 2件: 96, 97 💬 |
751 |
Omeprazole 40 mg |
Omeprazole |
4件: D00455 D00455, D01207 D01207, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 1件: 96 💬 |
752 |
Only 1 arm: treatment with msc-afp |
- |
- |
- |
- |
096 1件: 96 💬 |
753 |
Ontamalimab |
Ontamalimab |
- |
- |
- |
096 2件: 96, 97 💬 |
754 |
Opc-6535 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
755 |
Opc-6535(tetomilast) |
Tetomilast |
- |
- |
- |
096 2件: 96, 97 💬 |
756 |
Ops-2071 |
- |
- |
- |
- |
096 1件: 96 💬 |
757 |
Ops-2071 150 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
758 |
Ops-2071 300 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
759 |
Ops-2071 600 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
760 |
Optison |
- |
- |
- |
- |
096 1件: 96 💬 |
761 |
Orencia |
- |
- |
- |
- |
044 13件: 44, 46, 49, 50, 51, 53, 65, 84, 96, 97, 160, 222, 271 💬 |
762 |
Originator (legacy) drug |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
763 |
Other biologic therapies |
- |
- |
- |
- |
096 1件: 96 💬 |
764 |
Other biological agent |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
765 |
Other: 100% pomegranate juice |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
766 |
Other: 5-asa withdrawal |
Mesalazine |
1件: D00377 D00377 💬 |
- |
- |
096 1件: 96 💬 |
767 |
Other: acute response to high-impact exercise |
- |
- |
- |
- |
096 1件: 96 💬 |
768 |
Other: blood test |
- |
- |
- |
- |
096 1件: 96 💬 |
769 |
Other: cd lfd |
- |
- |
- |
- |
096 1件: 96 💬 |
770 |
Other: cd-treat diet |
- |
- |
- |
- |
096 1件: 96 💬 |
771 |
Other: coffee |
- |
- |
- |
- |
096 1件: 96 💬 |
772 |
Other: control diet |
- |
- |
- |
- |
096 1件: 96 💬 |
773 |
Other: crohn's disease treatment-with-eating diet (cd-treat diet) |
- |
- |
- |
- |
096 1件: 96 💬 |
774 |
Other: crohns disease exclusion diet |
- |
- |
- |
- |
096 1件: 96 💬 |
775 |
Other: diet-cd |
- |
- |
- |
- |
096 1件: 96 💬 |
776 |
Other: enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
777 |
Other: exclusion diet |
- |
- |
- |
- |
096 1件: 96 💬 |
778 |
Other: exclusive enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
779 |
Other: exclusive enteral nutrition (een) |
- |
- |
- |
- |
096 1件: 96 💬 |
780 |
Other: fractional exhaled no (feno) |
- |
- |
- |
- |
096 1件: 96 💬 |
781 |
Other: green tea (camellia sinensis) |
Green tea leaf |
1件: D06903 D06903 💬 |
- |
- |
096 1件: 96 💬 |
782 |
Other: high energy / protein diet. |
- |
- |
- |
- |
096 1件: 96 💬 |
783 |
Other: high performance liquid chromatography |
- |
- |
- |
- |
096 1件: 96 💬 |
784 |
Other: high-impact exercise intervention |
- |
- |
- |
- |
096 1件: 96 💬 |
785 |
Other: hyperbaric oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
096 1件: 96 💬 |
786 |
Other: infliximab (ifx) infusion |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
787 |
Other: intensify treatment with the existing drug |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
788 |
Other: iv saline infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
789 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 21件: 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
790 |
Other: lengthening adalimumab dosing interval |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
791 |
Other: leukapheresis- collection of stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
792 |
Other: low n-6 pufa diet |
- |
- |
- |
- |
096 1件: 96 💬 |
793 |
Other: measurement of drug (adalimumab/infliximab) |
Adalimumab |
2件: D02597 D02597, D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 2件: 96, 97 💬 |
794 |
Other: methacholine challenge test |
Methacholine |
- |
- |
- |
096 1件: 96 💬 |
795 |
Other: normal diet |
- |
- |
- |
- |
096 1件: 96 💬 |
796 |
Other: ns |
- |
- |
- |
- |
096 1件: 96 💬 |
797 |
Other: other biologic agents |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
798 |
Other: pcdai |
- |
- |
- |
- |
096 1件: 96 💬 |
799 |
Other: quality-of-life assessment |
- |
- |
- |
- |
034 5件: 34, 36, 51, 96, 298 💬 |
800 |
Other: questionnaires |
- |
- |
- |
- |
006 5件: 6 , 13, 41, 93, 96 💬 |
801 |
Other: standard nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
802 |
Other: standard of care |
- |
- |
- |
- |
013 7件: 13, 49, 64, 85, 96, 245, 246 💬 |
803 |
Other: stem cell transplant |
- |
- |
- |
- |
096 1件: 96 💬 |
804 |
Other: surgery |
- |
- |
- |
- |
074 2件: 74, 96 💬 |
805 |
Other: threonine |
Threonine |
1件: D00041 D00041 💬 |
- |
- |
096 2件: 96, 97 💬 |
806 |
Other: triangular test |
- |
- |
- |
- |
096 1件: 96 💬 |
807 |
Other: uc-mscs by peripheral intravenous infusion |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
096 1件: 96 💬 |
808 |
Ova-treg |
- |
- |
- |
- |
096 1件: 96 💬 |
809 |
Ovasave |
- |
- |
- |
- |
096 1件: 96 💬 |
810 |
Oxadrop |
- |
- |
- |
- |
096 1件: 96 💬 |
811 |
Oxygen |
Oxygen |
1件: D00003 D00003 💬 |
- |
- |
006 18件: 6 , 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 193, 226, 294, 299, 330 💬 |
812 |
Ozanimod |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 96, 97 💬 |
813 |
Ozanimod hydrochloride |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 3件: 13, 96, 97 💬 |
814 |
P28gst |
- |
- |
- |
- |
096 1件: 96 💬 |
815 |
Pda001 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
816 |
Pectin |
Pectin |
1件: D02316 D02316 💬 |
- |
- |
096 1件: 96 💬 |
817 |
Peg |
- |
- |
- |
- |
006 9件: 6 , 13, 46, 65, 78, 96, 97, 240, 299 💬 |
818 |
Pegylated interferon alfa |
Interferon alfa |
1件: D03305 D03305 💬 |
IFNAR1 2件: IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
096 1件: 96 💬 |
819 |
Pending |
- |
- |
- |
- |
013 6件: 13, 19, 96, 97, 113, 302 💬 |
820 |
Pentasa |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
821 |
Pentasa sachet |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
822 |
Pentasa sachet 1 g |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
823 |
Pentasa sachet 1 g prolonged release granules |
- |
- |
- |
- |
096 1件: 96 💬 |
824 |
Pentoxifylline |
Pentoxifylline |
1件: D00501 D00501 💬 |
- |
- |
026 10件: 26, 56, 84, 93, 96, 113, 220, 222, 296, 298 💬 |
825 |
Peptidic+probiotic |
- |
- |
- |
- |
096 1件: 96 💬 |
826 |
Peripheral blood stem cell infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
827 |
Pf 06687234 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
828 |
Pf-00547659 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
829 |
Pf-00547659 sc injection |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
830 |
Pf-04236921 |
- |
- |
- |
- |
049 2件: 49, 96 💬 |
831 |
Pf-04236921 sc injection |
- |
- |
- |
- |
096 1件: 96 💬 |
832 |
Pf-06651600 |
PF-06651600 |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
833 |
Pf-06651600 50 mg |
PF-06651600 |
- |
- |
- |
096 2件: 96, 97 💬 |
834 |
Pf-06651600-15 |
PF-06651600 |
- |
- |
- |
096 2件: 96, 97 💬 |
835 |
Pf-06700841 |
PF-06700841 |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
836 |
Pf-06700841 25 mg |
PF-06700841 |
- |
- |
- |
096 2件: 96, 97 💬 |
837 |
Pf-06700841 5 mg |
PF-06700841 |
- |
- |
- |
096 2件: 96, 97 💬 |
838 |
Pf-06700841-15 |
PF-06700841 |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
839 |
Pharmacokinetics of certolizumab pegol |
Certolizumab pegol |
1件: D03441 D03441 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 2件: 46, 96 💬 |
840 |
Phosphate |
Phosphate ion |
- |
- |
- |
002 30件: 2 , 3 , 11, 12, 13, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 256, 276, 283, 284, 285, 286, 299 💬 |
841 |
Phylloquinone |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
096 1件: 96 💬 |
842 |
Phylloquinone (vitamin k1) |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
096 1件: 96 💬 |
843 |
Physician standard-of-care |
- |
- |
- |
- |
096 1件: 96 💬 |
844 |
Pioglitazone |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
002 17件: 2 , 6 , 13, 15, 20, 46, 49, 65, 67, 78, 81, 86, 96, 229, 265, 298, 299 💬 |
845 |
Pioglitazone 15 mg |
Pioglitazone |
2件: D00945 D00945, D08378 D08378 💬 |
PPARG 1件: PPARG 💬 |
AMPK signaling pathway 9件: AMPK signaling pathway, Huntington disease, Longevity regulating pathway, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer |
096 1件: 96 💬 |
846 |
Pl 17901/0122 |
- |
- |
- |
- |
096 1件: 96 💬 |
847 |
Pl 20532/0012 |
- |
- |
- |
- |
096 1件: 96 💬 |
848 |
Placebo |
- |
- |
- |
- |
003 26件: 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
849 |
Plantain nsp |
- |
- |
- |
- |
096 1件: 96 💬 |
850 |
Plaquenil |
- |
- |
- |
- |
046 4件: 46, 49, 53, 96 💬 |
851 |
Plasma rico en plaquetas y coagulo de fibrina procesados mediante la tecnología prgf-system (bti) |
- |
- |
- |
- |
096 1件: 96 💬 |
852 |
Pnemovax |
- |
- |
- |
- |
096 1件: 96 💬 |
853 |
Pneumovax |
- |
- |
- |
- |
046 3件: 46, 49, 96 💬 |
854 |
Polaprezinc |
Polaprezinc |
1件: D01611 D01611 💬 |
- |
- |
096 2件: 96, 97 💬 |
855 |
Polyethylene glycol |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
096 5件: 96, 97, 235, 276, 299 💬 |
856 |
Polyethylene glycol 3350 |
Polyethylene glycol |
1件: D03370 D03370 💬 |
- |
- |
096 2件: 96, 299 💬 |
857 |
Pomegranate |
Pomegranate |
- |
- |
- |
096 2件: 96, 97 💬 |
858 |
Postoperative 3-month exclusive enteral nutrition |
- |
- |
- |
- |
096 1件: 96 💬 |
859 |
Pravastatin |
Pravastatin |
2件: D00893 D00893, D08410 D08410 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
013 9件: 13, 46, 49, 67, 79, 96, 164, 265, 333 💬 |
860 |
Prebiotics |
- |
- |
- |
- |
096 1件: 96 💬 |
861 |
Prednisolon |
- |
- |
- |
- |
046 6件: 46, 50, 51, 66, 96, 97 💬 |
862 |
Prednisolon jenapharm |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
863 |
Prednisolone |
Prednisolone |
8件: D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
011 40件: 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
864 |
Prednisone |
Prednisone |
1件: D00473 D00473 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
002 47件: 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
865 |
Preparative regimen 4-6 weeks after leukapheresis |
- |
- |
- |
- |
096 1件: 96 💬 |
866 |
Prevenar 13 |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
867 |
Previously referred to as medi2070 and amg 139 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
868 |
Previously referred to as medi2070 and amg 139, agn-151-598 |
- |
- |
- |
- |
096 1件: 96 💬 |
869 |
Probiotic |
- |
- |
- |
- |
002 7件: 2 , 6 , 93, 96, 97, 193, 266 💬 |
870 |
Probiotic - vsl#3 |
- |
- |
- |
- |
096 1件: 96 💬 |
871 |
Probiotic mixture |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
872 |
Probiotics |
- |
- |
- |
- |
094 4件: 94, 96, 97, 291 💬 |
873 |
Procedure: allogeneic bone marrow transplantation |
- |
- |
- |
- |
060 6件: 60, 65, 96, 164, 284, 285 💬 |
874 |
Procedure: apheresis catheter placement |
- |
- |
- |
- |
096 1件: 96 💬 |
875 |
Procedure: autologous stem cell transplant |
- |
- |
- |
- |
028 2件: 28, 96 💬 |
876 |
Procedure: blood sampling from infant |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
877 |
Procedure: blood sampling from mother |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
878 |
Procedure: blood sampling from umbilical cord |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
879 |
Procedure: blue light photopheresis |
- |
- |
- |
- |
096 1件: 96 💬 |
880 |
Procedure: breast milk sampling |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
881 |
Procedure: computed tomography |
- |
- |
- |
- |
034 5件: 34, 40, 46, 49, 96 💬 |
882 |
Procedure: continuous mononuclear cell collection (cmnc) |
- |
- |
- |
- |
096 1件: 96 💬 |
883 |
Procedure: dexa scan |
- |
- |
- |
- |
019 3件: 19, 46, 96 💬 |
884 |
Procedure: endoscopic balloon dilatation |
- |
- |
- |
- |
096 1件: 96 💬 |
885 |
Procedure: eua with seton placement if necessary |
- |
- |
- |
- |
096 1件: 96 💬 |
886 |
Procedure: eus |
- |
- |
- |
- |
096 1件: 96 💬 |
887 |
Procedure: extracorporeal photopheresis |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
888 |
Procedure: fmt |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
889 |
Procedure: ileocecal resection |
- |
- |
- |
- |
096 1件: 96 💬 |
890 |
Procedure: ileocolonoscopy |
- |
- |
- |
- |
096 1件: 96 💬 |
891 |
Procedure: instillation of fibrin glue |
- |
- |
- |
- |
096 1件: 96 💬 |
892 |
Procedure: intestinal surgery for crohn's disease |
- |
- |
- |
- |
096 1件: 96 💬 |
893 |
Procedure: leukapheresis |
- |
- |
- |
- |
049 5件: 49, 51, 96, 284, 285 💬 |
894 |
Procedure: lumbar puncture |
- |
- |
- |
- |
006 5件: 6 , 13, 19, 96, 97 💬 |
895 |
Procedure: measurement of serum infliximab and anti-infliximab antibodies |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
896 |
Procedure: positron emission tomography |
- |
- |
- |
- |
040 4件: 40, 46, 49, 96 💬 |
897 |
Procedure: routine drainage surgery |
- |
- |
- |
- |
096 1件: 96 💬 |
898 |
Procedure: small bowel follow trough |
- |
- |
- |
- |
096 1件: 96 💬 |
899 |
Procedure: transfusion |
- |
- |
- |
- |
096 1件: 96 💬 |
900 |
Procedure: treatment according to current standards without knowledge of serum infliximab and anti-infliximab ab status |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
901 |
Procedure: whole body protein turnover |
- |
- |
- |
- |
019 4件: 19, 46, 96, 299 💬 |
902 |
Procedure: wmt |
- |
- |
- |
- |
096 1件: 96 💬 |
903 |
Prochymal (remestemcel-l) |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
096 1件: 96 💬 |
904 |
Prochymal adult human mesenchymal stem cells |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
096 1件: 96 💬 |
905 |
Prochymal™ adult human mesenchymal stem cells |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
096 1件: 96 💬 |
906 |
Promethazine |
Promethazine |
4件: D00480 D00480, D00494 D00494, D01242 D01242, D03290 D03290 💬 |
HRH1 1件: HRH1 💬 |
Calcium signaling pathway 3件: Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
907 |
Prucalopride |
Prucalopride |
1件: D09205 D09205 💬 |
HTR4 1件: HTR4 💬 |
Calcium signaling pathway 4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, cAMP signaling pathway |
013 3件: 13, 51, 96 💬 |
908 |
Prv-6527 |
- |
- |
- |
- |
096 1件: 96 💬 |
909 |
Prv-6527 (jnj-40346527) |
JNJ-40346527 |
- |
- |
- |
096 1件: 96 💬 |
910 |
Prv-6527(jnj-40346527) |
JNJ-40346527 |
- |
- |
- |
096 1件: 96 💬 |
911 |
Ptg-200 |
- |
- |
- |
- |
096 1件: 96 💬 |
912 |
Puri-nethol |
- |
- |
- |
- |
086 3件: 86, 96, 97 💬 |
913 |
Puri-nethol 50 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
914 |
Purinethol |
- |
- |
- |
- |
096 1件: 96 💬 |
915 |
Qax567 |
- |
- |
- |
- |
096 1件: 96 💬 |
916 |
Qax576 |
- |
- |
- |
- |
051 4件: 51, 85, 96, 98 💬 |
917 |
Qbeco |
- |
- |
- |
- |
096 1件: 96 💬 |
918 |
Qbeco-ssi |
- |
- |
- |
- |
096 1件: 96 💬 |
919 |
Rabbit |
Rabbit |
- |
- |
- |
011 8件: 11, 13, 49, 51, 60, 65, 96, 285 💬 |
920 |
Rabbit anti-human thymocyte immunoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 2件: 13, 96 💬 |
921 |
Rabbit antithymocyte globulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
049 3件: 49, 60, 96 💬 |
922 |
Racol |
- |
- |
- |
- |
006 3件: 6 , 96, 291 💬 |
923 |
Rad001 |
- |
- |
- |
- |
034 6件: 34, 67, 89, 96, 158, 228 💬 |
924 |
Radiation: fluorine f 18 clofarabine |
Clofarabine |
1件: D03546 D03546 💬 |
POLA1 3件: POLA1, POLA2, RRM1 💬 |
DNA replication 6件: DNA replication, Drug metabolism - other enzymes, Glutathione metabolism, Metabolic pathways, Purine metabolism, Pyrimidine metabolism |
040 4件: 40, 46, 49, 96 💬 |
925 |
Radiation: total-body irradiation |
- |
- |
- |
- |
028 9件: 28, 51, 60, 62, 65, 96, 283, 284, 285 💬 |
926 |
Ranolazine |
Ranolazine |
2件: D05700 D05700, D05701 D05701 💬 |
- |
- |
002 6件: 2 , 58, 86, 96, 113, 114 💬 |
927 |
Rapamycin |
Sirolimus |
1件: D00753 D00753 💬 |
MTOR 1件: MTOR 💬 |
AMPK signaling pathway 50件: AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alzheimer disease, Amyotrophic lateral sclerosis, Apelin signaling pathway, Autophagy - animal, Autophagy - other, Breast cancer, Cellular senescence, Central carbon metabolism in cancer, Choline metabolism in cancer, Colorectal cancer, Diabetic cardiomyopathy, EGFR tyrosine kinase inhibitor resistance, Endocrine resistance, ErbB signaling pathway, Gastric cancer, Glioma, Growth hormone synthesis, secretion and action, HIF-1 signaling pathway, Hepatocellular carcinoma, Herpes simplex virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Huntington disease, Insulin resistance, Insulin signaling pathway, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Longevity regulating pathway, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Phospholipase D signaling pathway, Prostate cancer, Proteoglycans in cancer, Shigellosis, Spinocerebellar ataxia, Th17 cell differentiation, Thermogenesis, Thyroid hormone signaling pathway, Type II diabetes mellitus, mTOR signaling pathway |
002 18件: 2 , 15, 34, 35, 46, 49, 51, 60, 61, 67, 86, 89, 96, 157, 158, 256, 278, 279 💬 |
928 |
Raptiva |
- |
- |
- |
- |
011 9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 💬 |
929 |
Raptiva 100 mg/ml powder and solvent for solution for injection |
- |
- |
- |
- |
011 7件: 11, 13, 46, 53, 61, 95, 96 💬 |
930 |
Rbatg |
- |
- |
- |
- |
051 2件: 51, 96 💬 |
931 |
Rctb-401 |
- |
- |
- |
- |
096 1件: 96 💬 |
932 |
Received hormone maintenance therapy |
- |
- |
- |
- |
096 1件: 96 💬 |
933 |
Recombinant growth hormone |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
078 2件: 78, 96 💬 |
934 |
Recombinant human insulin-like growth factor |
Insulin human |
2件: D00085 D00085, D03230 D03230 💬 |
INSR 1件: INSR 💬 |
AMPK signaling pathway 22件: AMPK signaling pathway, Adherens junction, Aldosterone-regulated sodium reabsorption, Alzheimer disease, Diabetic cardiomyopathy, FoxO signaling pathway, HIF-1 signaling pathway, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, MAPK signaling pathway, Non-alcoholic fatty liver disease, Ovarian steroidogenesis, PI3K-Akt signaling pathway, Phospholipase D signaling pathway, Rap1 signaling pathway, Ras signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, cGMP-PKG signaling pathway, mTOR signaling pathway |
096 1件: 96 💬 |
935 |
Recombinant human interleukin-11 (rhil-11) |
Oprelvekin |
1件: D05266 D05266 💬 |
IL11RA 1件: IL11RA 💬 |
Cytokine-cytokine receptor interaction 3件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway |
096 1件: 96 💬 |
936 |
Remestemcel-l |
Remestemcel-L |
1件: D09719 D09719 💬 |
- |
- |
096 2件: 96, 97 💬 |
937 |
Remicade |
- |
- |
- |
- |
040 9件: 40, 46, 49, 56, 84, 85, 96, 97, 271 💬 |
938 |
Remicade (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
939 |
Remicade 100 mg |
- |
- |
- |
- |
056 2件: 56, 96 💬 |
940 |
Remicade 100 mg powder for concentrate for solution for infusion. |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
941 |
Remicade 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
942 |
Remsima |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
943 |
Remsima (infliximab) |
Infliximab |
1件: D02598 D02598 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
046 3件: 46, 96, 97 💬 |
944 |
Remsima - 100 mg polvere per concentrato per soluzione per infusione - uso endovenoso - flanconcino (vetro) - 1 flaconcino |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
945 |
Remsima 100 mg pulver til konsentrat til infusjonsvæske, oppløsning |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
946 |
Remsima and inflectra |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
947 |
Remsina |
- |
- |
- |
- |
096 1件: 96 💬 |
948 |
Rhamnose |
Rhamnose |
- |
- |
- |
096 1件: 96 💬 |
949 |
Rhb-104 |
- |
- |
- |
- |
013 2件: 13, 96 💬 |
950 |
Rhgh |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
076 4件: 76, 78, 96, 193 💬 |
951 |
Rhigf (increlex) |
- |
- |
- |
- |
096 1件: 96 💬 |
952 |
Rhumab to il-17a (igg1-k-class) |
- |
- |
- |
- |
013 4件: 13, 46, 56, 96 💬 |
953 |
Rhumab to il-17a (igg1-k-class) rhumab to il-17a (igg1-k-class) |
- |
- |
- |
- |
096 1件: 96 💬 |
954 |
Ribavirin |
Ribavirin |
1件: D00423 D00423 💬 |
- |
- |
002 2件: 2 , 96 💬 |
955 |
Riboflavin |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
013 8件: 13, 38, 46, 96, 97, 162, 168, 265 💬 |
956 |
Riboflavin sodium phosphate injection |
Phosphate ion |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
096 1件: 96 💬 |
957 |
Riboflavin supplementation |
Riboflavin |
3件: D00050 D00050, D01622 D01622, D01913 D01913 💬 |
- |
- |
096 1件: 96 💬 |
958 |
Rifabutin |
Rifabutin |
1件: D00424 D00424 💬 |
- |
- |
096 1件: 96 💬 |
959 |
Rifabutin, clarithromycin, and clofazimine |
Clarithromycin |
3件: D00276 D00276, D00278 D00278, D00424 D00424 💬 |
- |
- |
096 1件: 96 💬 |
960 |
Rifaximin |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
006 6件: 6 , 65, 96, 97, 99, 296 💬 |
961 |
Rifaximin delayed release (dr) |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
096 1件: 96 💬 |
962 |
Rifaximin delayed release 400 mg film coated tablet |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
096 1件: 96 💬 |
963 |
Rifaximin delayed release tablets |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
096 1件: 96 💬 |
964 |
Rifaximin eir |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
096 1件: 96 💬 |
965 |
Rifaximin+omeprazole+miralax |
Omeprazole |
5件: D00455 D00455, D01207 D01207, D02554 D02554, D05259 D05259, D05261 D05261 💬 |
ATP4A 2件: ATP4A, ATP4B 💬 |
Collecting duct acid secretion 4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation |
096 1件: 96 💬 |
966 |
Rifaximin-eir |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
096 1件: 96 💬 |
967 |
Rifaximina |
Rifaximin |
1件: D02554 D02554 💬 |
- |
- |
096 1件: 96 💬 |
968 |
Risankizumab |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
037 4件: 37, 96, 97, 271 💬 |
969 |
Risankizumab 10 mg/ml |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
970 |
Risankizumab 180 mg sc |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
971 |
Risankizumab 600 mg iv |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
972 |
Risankizumab 90 mg/ml |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 1件: 96 💬 |
973 |
Risankizumab iv |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
974 |
Risankizumab sc |
Risankizumab |
1件: D11052 D11052 💬 |
IL23A 1件: IL23A 💬 |
C-type lectin receptor signaling pathway 9件: C-type lectin receptor signaling pathway, Cytokine-cytokine receptor interaction, Inflammatory bowel disease, JAK-STAT signaling pathway, Pathways in cancer, Pertussis, Rheumatoid arthritis, Th17 cell differentiation, Tuberculosis |
096 2件: 96, 97 💬 |
975 |
Risedronate |
Risedronic acid |
3件: D00942 D00942, D03234 D03234, D08484 D08484 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
046 6件: 46, 50, 66, 96, 113, 274 💬 |
976 |
Rituximab |
Rituximab |
1件: D02994 D02994 💬 |
MS4A1 1件: MS4A1 💬 |
Hematopoietic cell lineage 1件: Hematopoietic cell lineage |
011 47件: 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
977 |
Rizankisumab |
- |
- |
- |
- |
096 1件: 96 💬 |
978 |
Rizankizumab |
- |
- |
- |
- |
096 1件: 96 💬 |
979 |
Ro 549-0261/f04-02 |
- |
- |
- |
- |
096 1件: 96 💬 |
980 |
Ro 549-0261/f08-02 |
- |
- |
- |
- |
096 1件: 96 💬 |
981 |
Rosuvastatin |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
006 11件: 6 , 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 💬 |
982 |
Rosuvastatin 10 mg |
Rosuvastatin |
2件: D01915 D01915, D08492 D08492 💬 |
HMGCR 1件: HMGCR 💬 |
AMPK signaling pathway 4件: AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis |
096 1件: 96 💬 |
983 |
Routine treatment of cd |
- |
- |
- |
- |
096 1件: 96 💬 |
984 |
Rpc0163 |
- |
- |
- |
- |
096 1件: 96 💬 |
985 |
Rpc1063 |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
986 |
Rpc1063 (equivalent to ozanimod |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 1件: 96 💬 |
987 |
Rpc1063 (equivalent to ozanimod hcl) |
Ozanimod |
1件: D10968 D10968 💬 |
S1PR1 5件: S1PR1, S1PR2, S1PR3, S1PR4, S1PR5 💬 |
FoxO signaling pathway 3件: FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
096 1件: 96 💬 |
988 |
Rr110 (tamibarotene) |
Tamibarotene |
1件: D01418 D01418 💬 |
RARA 1件: RARA 💬 |
Acute myeloid leukemia 5件: Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
096 1件: 96 💬 |
989 |
Rvg 05565 |
- |
- |
- |
- |
096 1件: 96 💬 |
990 |
Rvg 07151 |
- |
- |
- |
- |
096 1件: 96 💬 |
991 |
S38 |
- |
- |
- |
- |
096 1件: 96 💬 |
992 |
Salmon |
Salmon, unspecified |
- |
- |
- |
096 3件: 96, 97, 225 💬 |
993 |
Salofalk |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
994 |
Salofalk 500 mg |
- |
- |
- |
- |
096 1件: 96 💬 |
995 |
Sandostatine |
- |
- |
- |
- |
096 1件: 96 💬 |
996 |
Sargramostim |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
006 7件: 6 , 28, 60, 62, 96, 229, 285 💬 |
997 |
Sargramostim (leukine) |
Sargramostim |
1件: D05803 D05803 💬 |
CSF2RA 1件: CSF2RA 💬 |
Cytokine-cytokine receptor interaction 4件: Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, Pathways in cancer |
096 1件: 96 💬 |
998 |
Sb5 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
999 |
Sc12267 |
SC12267 |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
1000 |
Sc12267 (4sc-101) |
SC12267 |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
1001 |
Search for exocrine pancreatic insufficiency at week 0 and 12 |
- |
- |
- |
- |
096 1件: 96 💬 |
1002 |
Selective immunosuppressive agents |
- |
- |
- |
- |
096 1件: 96 💬 |
1003 |
Semapimod |
Semapimod |
- |
- |
- |
096 1件: 96 💬 |
1004 |
Serum albumine 5% |
- |
- |
- |
- |
096 1件: 96 💬 |
1005 |
Serum bovine immunoglobulin |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1006 |
Serum physiologique 0.9 % |
- |
- |
- |
- |
096 1件: 96 💬 |
1007 |
Shingrix |
- |
- |
- |
- |
046 3件: 46, 96, 97 💬 |
1008 |
Shp647 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1009 |
Shr0302 |
- |
- |
- |
- |
046 4件: 46, 96, 97, 271 💬 |
1010 |
Sibofimloc |
Sibofimloc |
1件: D11825 D11825 💬 |
- |
- |
096 1件: 96 💬 |
1011 |
Simethicone |
Simethicone |
1件: D05841 D05841 💬 |
- |
- |
013 2件: 13, 96 💬 |
1012 |
Sivelestat |
Sivelestat |
1件: D03788 D03788 💬 |
ELANE 1件: ELANE 💬 |
Neutrophil extracellular trap formation 3件: Neutrophil extracellular trap formation, Systemic lupus erythematosus, Transcriptional misregulation in cancer |
013 3件: 13, 85, 96 💬 |
1013 |
Smoflipid |
- |
- |
- |
- |
096 1件: 96 💬 |
1014 |
Smoking cigarettes |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1015 |
Smoking of cannabis |
Medical Cannabis |
- |
- |
- |
096 2件: 96, 97 💬 |
1016 |
Sodium chloride |
Chloride ion |
1件: D02056 D02056 💬 |
- |
- |
006 20件: 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
1017 |
Solid food-based intervention |
- |
- |
- |
- |
096 1件: 96 💬 |
1018 |
Somatropin |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
002 16件: 2 , 3 , 19, 46, 74, 75, 78, 96, 113, 187, 193, 195, 265, 274, 276, 299 💬 |
1019 |
Somatropin [rdna origin] for injection |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
046 2件: 46, 96 💬 |
1020 |
Somatropin(rhgh) |
Somatotropin |
1件: D02691 D02691 💬 |
GHR 1件: GHR 💬 |
Cytokine-cytokine receptor interaction 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway |
096 1件: 96 💬 |
1021 |
Sonovue |
- |
- |
- |
- |
096 1件: 96 💬 |
1022 |
Soy protein |
- |
- |
- |
- |
006 2件: 6 , 96 💬 |
1023 |
Soya bean oil |
Bean |
- |
- |
- |
096 1件: 96 💬 |
1024 |
Spesolilmab |
- |
- |
- |
- |
096 1件: 96 💬 |
1025 |
Spesolimab |
Spesolimab |
- |
- |
- |
037 3件: 37, 96, 97 💬 |
1026 |
St10 |
- |
- |
- |
- |
096 1件: 96 💬 |
1027 |
St10-021 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1028 |
Sta-5326 |
- |
- |
- |
- |
065 2件: 65, 96 💬 |
1029 |
Sta-5326 mesylate |
- |
- |
- |
- |
096 1件: 96 💬 |
1030 |
Sta-6838, sta-5326 m, s38 |
- |
- |
- |
- |
096 1件: 96 💬 |
1031 |
Stable isotope infusions |
- |
- |
- |
- |
096 1件: 96 💬 |
1032 |
Standard 2 hours-infusion |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1033 |
Standard step-up care |
- |
- |
- |
- |
096 1件: 96 💬 |
1034 |
Start adalimumab in monotherapy |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
1035 |
Stelara |
- |
- |
- |
- |
049 6件: 49, 56, 96, 97, 269, 271 💬 |
1036 |
Stelara 130 mg concentrate for solution for infusion |
- |
- |
- |
- |
096 1件: 96 💬 |
1037 |
Stelara 90 mg solution for injection in pre-filled syringe |
- |
- |
- |
- |
096 1件: 96 💬 |
1038 |
Stelara, remicade, entyvio, humira, remsima, flixabi, inflectra |
- |
- |
- |
- |
096 1件: 96 💬 |
1039 |
Stelara® |
- |
- |
- |
- |
049 3件: 49, 96, 97 💬 |
1040 |
Stem cells |
- |
- |
- |
- |
002 4件: 2 , 4 , 96, 113 💬 |
1041 |
Step-up |
- |
- |
- |
- |
096 1件: 96 💬 |
1042 |
Steroids |
- |
- |
- |
- |
046 7件: 46, 50, 51, 63, 66, 96, 97 💬 |
1043 |
Stromal vascular fraction (svf) |
- |
- |
- |
- |
096 1件: 96 💬 |
1044 |
Sub20016 |
- |
- |
- |
- |
096 1件: 96 💬 |
1045 |
Sucrose |
Sucrose |
1件: D00025 D00025 💬 |
- |
- |
062 3件: 62, 96, 97 💬 |
1046 |
Sugar extract |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1047 |
Sulfate |
Sulfate ion |
- |
- |
- |
002 25件: 2 , 6 , 11, 13, 26, 28, 34, 36, 46, 49, 53, 60, 64, 66, 79, 85, 86, 96, 111, 222, 226, 265, 296, 297, 299 💬 |
1048 |
Sulfur hexafluoride |
Sulfur hexafluoride |
1件: D05962 D05962 💬 |
- |
- |
096 1件: 96 💬 |
1049 |
Sulphur hexafluoride |
Sulfur hexafluoride |
1件: D05962 D05962 💬 |
- |
- |
096 1件: 96 💬 |
1050 |
Suspension containing 250 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1051 |
Suspension containing 250 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1052 |
Suspension containing 2500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1053 |
Suspension containing 2500 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1054 |
Suspension containing 7500 embryonated, viable trichuris suis ova (tso)/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1055 |
Suspension of 7500 embryonated, viable tso/15ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1056 |
Suspension of adipose derived autologous adult stem cells |
- |
- |
- |
- |
096 1件: 96 💬 |
1057 |
Synbiotic (synergy i / b.longum) |
- |
- |
- |
- |
096 1件: 96 💬 |
1058 |
T2 |
- |
- |
- |
- |
096 1件: 96 💬 |
1059 |
Ta-650 |
- |
- |
- |
- |
037 4件: 37, 56, 96, 97 💬 |
1060 |
Tacrolimus |
Tacrolimus |
2件: D00107 D00107, D08556 D08556 💬 |
PPP3CA 5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 |
Alzheimer disease 32件: Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway |
002 32件: 2 , 6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬 |
1061 |
Tak-018 |
- |
- |
- |
- |
096 1件: 96 💬 |
1062 |
Tamibarotene |
Tamibarotene |
1件: D01418 D01418 💬 |
RARA 1件: RARA 💬 |
Acute myeloid leukemia 5件: Acute myeloid leukemia, Estrogen signaling pathway, Pathways in cancer, Th17 cell differentiation, Transcriptional misregulation in cancer |
026 2件: 26, 96 💬 |
1063 |
Tasty&healthy intervention group |
- |
- |
- |
- |
096 1件: 96 💬 |
1064 |
Tbc |
- |
- |
- |
- |
085 3件: 85, 94, 96 💬 |
1065 |
Td-1473 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1066 |
Teduglutide |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
1067 |
Teduglutide (alx-0600) |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
1068 |
Teduglutide 0.05 |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
1069 |
Teduglutide 0.05 dose |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
1070 |
Teduglutide 0.1 mg dose |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
1071 |
Teduglutide 0.2 mg |
Teduglutide |
1件: D06053 D06053 💬 |
GLP2R 1件: GLP2R 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
096 1件: 96 💬 |
1072 |
Tetomilast |
Tetomilast |
- |
- |
- |
096 2件: 96, 97 💬 |
1073 |
Thalidomide |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
002 20件: 2 , 16, 20, 28, 49, 51, 53, 56, 65, 84, 85, 94, 96, 97, 227, 271, 280, 298, 300, 331 💬 |
1074 |
Thalidomide celgene - 50 mg capsula rigida - uso orale - blister (pvc/pe/aclar/alu) 28 capsule |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
1075 |
Thalidomide pharmion |
Thalidomide |
1件: D00754 D00754 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
085 3件: 85, 96, 97 💬 |
1076 |
Thc |
- |
- |
- |
- |
008 4件: 8 , 13, 46, 96 💬 |
1077 |
Thc 5mg/ml and cbs 50mg/ml |
- |
- |
- |
- |
096 1件: 96 💬 |
1078 |
The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. |
- |
- |
- |
- |
096 1件: 96 💬 |
1079 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta |
- |
- |
- |
- |
096 1件: 96 💬 |
1080 |
The investigational medicinal product (imp) will be labeled as pf-04236921 106 mg/vial, clonal sc lyophilized form, which is equivalent to pf-04236921 powder for injection, 106 mg/vial as described in the enclosed cta. |
- |
- |
- |
- |
096 1件: 96 💬 |
1081 |
Thetanix |
- |
- |
- |
- |
096 1件: 96 💬 |
1082 |
Thiopurine |
- |
- |
- |
- |
096 1件: 96 💬 |
1083 |
Thiotepa |
Thiotepa |
1件: D00583 D00583 💬 |
- |
- |
013 11件: 13, 19, 20, 28, 51, 60, 65, 85, 96, 164, 284 💬 |
1084 |
Threonine |
Threonine |
1件: D00041 D00041 💬 |
- |
- |
086 3件: 86, 96, 97 💬 |
1085 |
Thrx-139060 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1086 |
Thymoglobulin |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
036 6件: 36, 51, 60, 65, 96, 326 💬 |
1087 |
Thymoglobuline |
Antithymocyte immunoglobulin (rabbit) |
- |
- |
- |
013 5件: 13, 36, 51, 60, 96 💬 |
1088 |
Ticilimumab |
Tremelimumab |
1件: D06657 D06657 💬 |
CTLA4 1件: CTLA4 💬 |
Autoimmune thyroid disease 4件: Autoimmune thyroid disease, Cell adhesion molecules, Rheumatoid arthritis, T cell receptor signaling pathway |
096 1件: 96 💬 |
1089 |
Time and attention |
- |
- |
- |
- |
096 1件: 96 💬 |
1090 |
Time and attention + active fructooligosaccharide supplementation |
- |
- |
- |
- |
096 1件: 96 💬 |
1091 |
Tnf kinoid |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
1092 |
Tnf-alpha antagonists |
- |
- |
- |
- |
046 3件: 46, 96, 271 💬 |
1093 |
Tnf-k |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
1094 |
Tnf-kinoid |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
1095 |
Tnfa kinoid |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
1096 |
Tnfa-kinoid |
- |
- |
- |
- |
096 1件: 96 💬 |
1097 |
To be determined |
- |
- |
- |
- |
096 1件: 96 💬 |
1098 |
To be requested |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1099 |
Tofacitinib |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
011 12件: 11, 40, 46, 49, 50, 51, 53, 84, 96, 97, 107, 271 💬 |
1100 |
Tofacitinib (cp-690,550) |
Tofacitinib |
1件: D09970 D09970 💬 |
JAK1 4件: JAK1, JAK2, JAK3, TYK2 💬 |
AGE-RAGE signaling pathway in diabetic complications 35件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
096 1件: 96 💬 |
1101 |
Tolerogenic dendritic cells |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
1102 |
Top-down |
- |
- |
- |
- |
096 1件: 96 💬 |
1103 |
Tr004 (treg immunotherapy) |
- |
- |
- |
- |
096 1件: 96 💬 |
1104 |
Treatment with adalimumab |
Adalimumab |
1件: D02597 D02597 💬 |
TNF 1件: TNF 💬 |
AGE-RAGE signaling pathway in diabetic complications 65件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, MAPK signaling pathway, Malaria, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Non-alcoholic fatty liver disease, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway |
096 1件: 96 💬 |
1105 |
Triamcinolone |
Triamcinolone |
5件: D00385 D00385, D00983 D00983, D00984 D00984, D00985 D00985, D06216 D06216 💬 |
NR3C1 1件: NR3C1 💬 |
Neuroactive ligand-receptor interaction 1件: Neuroactive ligand-receptor interaction |
035 8件: 35, 46, 56, 70, 90, 96, 226, 298 💬 |
1106 |
Trichuris suis eggs |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1107 |
Trichuris suis ova |
- |
- |
- |
- |
013 4件: 13, 46, 96, 97 💬 |
1108 |
Trichuris suis ova (tso) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1109 |
Trichuris trichiura eggs |
- |
- |
- |
- |
096 1件: 96 💬 |
1110 |
Tripterygium |
Tripterygium wilfordii whole |
- |
- |
- |
046 8件: 46, 66, 67, 96, 162, 222, 224, 271 💬 |
1111 |
Tripterygium glycosides |
Tripterygium wilfordii whole |
- |
- |
- |
096 1件: 96 💬 |
1112 |
Tris |
Tromethamine |
1件: D00396 D00396 💬 |
- |
- |
096 2件: 96, 97 💬 |
1113 |
Trk-170 |
- |
- |
- |
- |
096 1件: 96 💬 |
1114 |
Tso 250 |
- |
- |
- |
- |
096 1件: 96 💬 |
1115 |
Tso 2500 |
- |
- |
- |
- |
096 1件: 96 💬 |
1116 |
Tso 7500 |
- |
- |
- |
- |
096 1件: 96 💬 |
1117 |
Tu-100 |
TU-100 |
- |
- |
- |
096 1件: 96 💬 |
1118 |
Tv-5600 |
- |
- |
- |
- |
008 3件: 8 , 13, 96 💬 |
1119 |
Uc-mscs |
Human Umbilical Cord Mesenchymal Stem Cells |
- |
- |
- |
046 2件: 46, 96 💬 |
1120 |
Ultrasound microbubble contrast agent |
- |
- |
- |
- |
096 1件: 96 💬 |
1121 |
Undetermined |
- |
- |
- |
- |
096 1件: 96 💬 |
1122 |
Upadacitinib |
Upadacitinib |
1件: D10994 D10994 💬 |
JAK1 1件: JAK1 💬 |
Coronavirus disease - COVID-19 27件: Coronavirus disease - COVID-19, EGFR tyrosine kinase inhibitor resistance, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Viral carcinogenesis |
040 7件: 40, 41, 46, 49, 96, 97, 271 💬 |
1123 |
Ursodeoxycholic acid |
Ursodeoxycholic acid |
1件: D00734 D00734 💬 |
NR1H4 1件: NR1H4 💬 |
Bile secretion 1件: Bile secretion |
006 8件: 6 , 67, 84, 93, 94, 95, 96, 97 💬 |
1124 |
Ursofalk |
- |
- |
- |
- |
093 4件: 93, 94, 96, 97 💬 |
1125 |
Ursofalk® 250 mg tabletten. |
- |
- |
- |
- |
096 1件: 96 💬 |
1126 |
Us tap bupivacaine/epinephrine |
Bupivacaine |
5件: D00095 D00095, D00996 D00996, D01450 D01450, D02149 D02149, D07552 D07552 💬 |
ADRA1A 14件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 |
AMPK signaling pathway 15件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Dopaminergic synapse, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Taste transduction, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 1件: 96 💬 |
1127 |
Ustekinumab |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
037 15件: 37, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬 |
1128 |
Ustekinumab (6 mg/kg) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1129 |
Ustekinumab (90 mg) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1130 |
Ustekinumab 130 mg iv |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1131 |
Ustekinumab 1mg/kg (ip) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1132 |
Ustekinumab 3 mg/kg (ip) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1133 |
Ustekinumab 4.5 mg/kg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1134 |
Ustekinumab 6 mg/kg (ip) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1135 |
Ustekinumab 90 mg |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
049 4件: 49, 50, 93, 96 💬 |
1136 |
Ustekinumab 90 mg (sc) group 1 |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1137 |
Ustekinumab 90 mg (sc) group 2 |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1138 |
Ustekinumab 90 mg sc q12w |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1139 |
Ustekinumab 90 mg sc q8w |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1140 |
Ustekinumab approximately 6 mg/kg (iv) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1141 |
Ustekinumab iv - nonresponder - ustekinumab 90mg sc (mp) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1142 |
Ustekinumab iv - responder - ustekinumab 90mg sc (mp) |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 1件: 96 💬 |
1143 |
Ustekinumab iv infusion |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 2件: 96, 97 💬 |
1144 |
Ustekinumab sc injection |
Ustekinumab |
1件: D09214 D09214 💬 |
IL12A 3件: IL12A, IL12B, IL23A 💬 |
African trypanosomiasis 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus |
096 2件: 96, 97 💬 |
1145 |
Usual current care |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1146 |
Uttr1147a |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1147 |
Uttr1147a, il22-fc, il-22fc |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1148 |
Uttr1147a/ro7021610 (active) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1149 |
Uvadex |
- |
- |
- |
- |
046 2件: 46, 96 💬 |
1150 |
Uvadex and uvar xts photopheresis system |
- |
- |
- |
- |
096 1件: 96 💬 |
1151 |
V565 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1152 |
Vancomycin |
Vancomycin |
2件: D00212 D00212, D00926 D00926 💬 |
- |
- |
046 7件: 46, 70, 94, 96, 97, 296, 299 💬 |
1153 |
Vedolizumab |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 3件: 94, 96, 97 💬 |
1154 |
Vedolizumab (genetical recombination) |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 1件: 96 💬 |
1155 |
Vedolizumab 300 mg injection [entyvio] |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 1件: 96 💬 |
1156 |
Vedolizumab intravenous injection |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1157 |
Vedolizumab iv |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
094 3件: 94, 96, 97 💬 |
1158 |
Vedolizumab iv (entyvio™) |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 1件: 96 💬 |
1159 |
Vedolizumab iv 300 mg |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 1件: 96 💬 |
1160 |
Vedolizumab sc |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1161 |
Vedolizumab sc 108 mg |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1162 |
Vedolizumab subcutaneous injection |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 2件: 96, 97 💬 |
1163 |
Vedolizumab-800cw |
Vedolizumab |
1件: D08083 D08083 💬 |
ITGA4 2件: ITGA4, ITGB7 💬 |
Arrhythmogenic right ventricular cardiomyopathy 15件: Arrhythmogenic right ventricular cardiomyopathy, Cell adhesion molecules, Dilated cardiomyopathy, ECM-receptor interaction, Focal adhesion, Hematopoietic cell lineage, Human papillomavirus infection, Hypertrophic cardiomyopathy, Intestinal immune network for IgA production, Leishmaniasis, Leukocyte transendothelial migration, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Yersinia infection |
096 1件: 96 💬 |
1164 |
Vehice control |
- |
- |
- |
- |
096 1件: 96 💬 |
1165 |
Verapamil |
Verapamil |
2件: D00619 D00619, D02356 D02356 💬 |
CACNA1C 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 |
Adrenergic signaling in cardiomyocytes 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway |
096 3件: 96, 140, 167 💬 |
1166 |
Viagra |
- |
- |
- |
- |
086 3件: 86, 96, 225 💬 |
1167 |
Vialebex |
- |
- |
- |
- |
096 1件: 96 💬 |
1168 |
Vialebex 200mg |
- |
- |
- |
- |
096 1件: 96 💬 |
1169 |
Vidofludimus |
Vidofludimus |
- |
- |
- |
013 5件: 13, 46, 94, 96, 97 💬 |
1170 |
Vidofludimus calcium |
Calcium |
- |
- |
- |
013 4件: 13, 94, 96, 97 💬 |
1171 |
Vigantol |
- |
- |
- |
- |
013 4件: 13, 65, 96, 97 💬 |
1172 |
Vigantol oel |
- |
- |
- |
- |
013 3件: 13, 96, 97 💬 |
1173 |
Vigantol oel tm |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1174 |
Visilizumab |
Visilizumab |
1件: D06314 D06314 💬 |
CD3D 3件: CD3D, CD3E, CD3G 💬 |
Chagas disease 11件: Chagas disease, Epstein-Barr virus infection, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human immunodeficiency virus 1 infection, Measles, PD-L1 expression and PD-1 checkpoint pathway in cancer, Primary immunodeficiency, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation |
096 2件: 96, 97 💬 |
1175 |
Vitamin d |
Vitamin D |
- |
- |
- |
013 21件: 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 98, 179, 222, 228, 235, 274, 298, 299 💬 |
1176 |
Vitamin d drops |
Vitamin D |
- |
- |
- |
096 2件: 96, 97 💬 |
1177 |
Vitamin d3 |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
006 11件: 6 , 13, 20, 46, 49, 53, 60, 65, 96, 97, 299 💬 |
1178 |
Vitamin d3 3000 ui daily |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
1179 |
Vitamin d3 4000 ui daily |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
1180 |
Vitamin d3 800 ui/day then 800 ui/day |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
1181 |
Vitamin d3: 3000 or 4000 ui/day then 2,000 ui/day |
Cholecalciferol |
1件: D00188 D00188 💬 |
VDR 1件: VDR 💬 |
Endocrine and other factor-regulated calcium reabsorption 4件: Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis |
096 1件: 96 💬 |
1182 |
Vitamin e |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
002 11件: 2 , 6 , 13, 20, 46, 90, 96, 97, 206, 299, 317 💬 |
1183 |
Vitamin e 800iu |
Vitamin E |
1件: D02331 D02331 💬 |
- |
- |
096 2件: 96, 97 💬 |
1184 |
Vitamin k |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
013 5件: 13, 46, 96, 97, 299 💬 |
1185 |
Vitamin k 10 mg |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
096 2件: 96, 97 💬 |
1186 |
Vitamin k1 |
Phylloquinone |
1件: D00148 D00148 💬 |
- |
- |
096 1件: 96 💬 |
1187 |
Vorinostat |
Vorinostat |
1件: D06320 D06320 💬 |
HDAC1 11件: HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC4, HDAC5, HDAC6, HDAC7, HDAC8, HDAC9 💬 |
Alcoholism 17件: Alcoholism, Amphetamine addiction, Amyotrophic lateral sclerosis, Apelin signaling pathway, Cell cycle, Chronic myeloid leukemia, Epstein-Barr virus infection, Human papillomavirus infection, Huntington disease, Longevity regulating pathway - multiple species, MicroRNAs in cancer, Neutrophil extracellular trap formation, Notch signaling pathway, Pathways in cancer, Thyroid hormone signaling pathway, Transcriptional misregulation in cancer, Viral carcinogenesis |
019 3件: 19, 75, 96 💬 |
1188 |
Vsl#3 |
- |
- |
- |
- |
096 3件: 96, 97, 291 💬 |
1189 |
Vsl#3 (original de simone formulation) |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1190 |
Vsl#3® |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1191 |
Warfarin |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
006 11件: 6 , 8 , 13, 19, 46, 49, 66, 85, 88, 96, 97 💬 |
1192 |
Warfarin 10 mg |
Warfarin |
3件: D00564 D00564, D01280 D01280, D08682 D08682 💬 |
NQO1 2件: NQO1, VKORC1 💬 |
Biosynthesis of cofactors 6件: Biosynthesis of cofactors, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Metabolic pathways, Pathways in cancer, Ubiquinone and other terpenoid-quinone biosynthesis |
096 2件: 96, 97 💬 |
1193 |
Water |
Water |
1件: D00001 D00001 💬 |
- |
- |
002 22件: 2 , 5 , 6 , 13, 17, 19, 35, 46, 51, 53, 56, 57, 63, 65, 67, 78, 84, 96, 97, 226, 278, 299 💬 |
1194 |
Wellbutrin (bupropion) |
Bupropion |
3件: D00817 D00817, D07591 D07591, D07938 D07938 💬 |
SLC6A2 2件: SLC6A2, SLC6A3 💬 |
Alcoholism 7件: Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle |
096 1件: 96 💬 |
1195 |
Wfi |
- |
- |
- |
- |
096 1件: 96 💬 |
1196 |
Whey protein |
- |
- |
- |
- |
006 2件: 6 , 96 💬 |
1197 |
Wmt |
- |
- |
- |
- |
096 1件: 96 💬 |
1198 |
Xanthohumol |
Xanthohumol |
- |
- |
- |
096 1件: 96 💬 |
1199 |
Z-206 |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1200 |
Zessly |
- |
- |
- |
- |
096 2件: 96, 97 💬 |
1201 |
Zoledronic acid |
Zoledronic acid |
4件: D01968 D01968, D06378 D06378, D06379 D06379, D08689 D08689 💬 |
FDPS 1件: FDPS 💬 |
Human T-cell leukemia virus 1 infection 4件: Human T-cell leukemia virus 1 infection, Influenza A, Metabolic pathways, Terpenoid backbone biosynthesis |
006 9件: 6 , 13, 46, 93, 95, 96, 274, 299, 333 💬 |
1202 |
Zp1848 |
- |
- |
- |
- |
096 1件: 96 💬 |
1203 |
Ácido gadobénico |
- |
- |
- |
- |
096 1件: 96 💬 |